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This report documents modifications and further test of
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URINE SAMPLING AND COLLECTION SYSTEM
OPTIMIZATION AND TESTING
1.0	 SUMMARY
A Urine Sampling and Collection System	 USCS	 engineering model was developedp
	9	 Y	 ( )	 9	 9 p
} for NASA-JSC by GE under NASA Contract NAS 9-10741, Phase $4. 	 The USCS
provided for the automatic collection, volume sensing and sampling of urine
from each micturition:	 The purpose of the engineering model was to demonstrate
1	 ; verification of the system concept.
The objective of the USCS Optimization and Testing program was to update the
featuresengineering model, to provide additional performance 	 and to conduct
system testing to determine operational problems.	 Optimization tasks were
defined asmodifications to minimize system fluid residual and addition of
thermoelectric cooling.
The USCS optimization tasks were completed as planned. 	 However, prior to
the start of system testing, and at NASA direction, the modified USCS engi-
neering model was diverted for urgent use under NASA Contract NAS 9-13519,
ASTP Fluid Transfer Measurement Experiment..	 Subsequently, NASA directed that !
in lieu of tests on the USCS engineering model, similar tests be conducted
using the Automated Biowaste Sampling System (ABSS) Urine Subsystem as the
h test hardware (developed under NASA Contract NASI-11443)_. 	 -
i
The ABSS was tested in the laboratory to determine biochemical and micro
biologicalcal responses, including Betadine disinfectant studies, to the presence
` of urine.	 Testing was.divided into 4 discrete experiments totaling 29 days
Ft
_
a
A 
of operation which included 28.3 liters of urine (143 inputs). Results are
summarized below:
	
'.$«	 Biochemical Responses
• ABSS embodies a constant 18 ml fluid residual within the fluid
j
pathways.
• The 18 ml residual is composed of an unknown proportion of rinse
water and the previous urine.
	
il 	 • Successive urine inputs are diluted by the residual.
• Urine inputs containing high concentrations of biochemical constituents
will cross-contaminate succeeding urine inputs.
	
P	 Microbiological Responses
• Fluid pathways within the ABSS contain a number of reservoirs (dead
	
a .,
	 ends, cracks, etc.) which quickly capture and hold available micro
+	 biological organisms within the ABSS.
^:	 r
• These pockets, or microbial reservoirs, re-infect (cross contaminate)
all incoming fluids.
• Frequent rinsing with normal urine inputs did not reduce the high
	
s	 titers (ti 10 7 ) maintained within these pockets
a
• The waste urine tank at ambient temperatures provides excellent media'
	
i r	 for rapid multiplication of microbial organisms with concomitant
production of
High titers of microorganisms (ti 10 8 )
	
;II	 Gas Pressure	 Positive or Negative
•` Peracetic acid (2%) flush was unable to eliminate the pockets of
contamination within the ABSS fluid pathways.
IA
Betadine Disinfection Studies
c
•	 Betadine at concentrations of up to 578 ppm of free I22 was ineffective
in either reducing or controlling populations of the E. coli marker,
or the naturally occurring urine contaminants within fhe f uid
- pathways of the ABSS
yy
" .^ •	 Betadine at concentrations averaging 727g	 g,	 ppm of free. I2 appeared to
inhibit the formation of gas pressure (positive or negative) in the
waste urine reservoir of the WCS simulation.
r
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The ABSS Microbiological Samplers (MS) are devices designed to provide an
unadulterated (with previous fluids) urine sample for microbiological assay.
Testing was performed to determine the sensitivity, and quantitative recovery
of bacteria from the MS. Data indicated the MS provides both a sensitive
and quantitative means of obtaining a real-time urine sample for microbio-
logical testing. >Nowever, operational experience indicated that manipulation
of the samplers was awkward, entailed a definite contamination risk, and
required excessive operator involvement.
2.0 BACKGROUND
A Urine Sampling and Collection System (USCS) engineering model was developed_
for NASA-JSC by GE under NASA Contract NAS 9-10741, Phase B4. The USCS
provided for the automatic collection, volume sensing and sampling of urine
from each micturition. The purpose of the engineering model was to demonstrate
verification of the system concept. This was accomplished; the engineering
model was delivered to NASA-JSC during December 1971 and successfully
demonstrated. However, because of program limitations, system level testing
of the USCS engineering model was limited essentially to checkout activity.
The objective of the USCS Optimization and Testing program was to update
the engineering model, as developed under Contract NAS9-10741, to provide
additional performance features and to conduct system testing to determine
IA
operational problems. Optimization tasks were defined as modifications to
minimize system fluid residual and addition of thermoelectric cooling.
a
The USCS optimization tasks were completed as planned. However, prior to
the start of system testing, and at NASA direction, the modified USCS engineering
{
model was diverted-for urgent use under NASA Contract NAS 9-13519, ASTP Fluid
3
z
Transfer Measurement Experiment. 	 Subsequently, NASA directed that in lies
of tests on the USCS engineering model, similar tests be conducted using the
ABSS Urine Subsystem as the test hardware (developed under NASA Contract
NAS1-11443).
Thus the program results reported in the following section describe the
USCS modifications followed by ABSS Urine Subsystem test results.
i
;c
r
4
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3.0 OPTIMIZATION AND TESTING
M;
3.1 USCS Modifications	 ,, w
The USCS, as developed under Contract NAS 9 -10741, is described in detail
in GE Report No. 70SD5414.	 "`*
3.1.1 Residual Volume Minimization	 ^s
Residual volume directly effects the degree of cross-contamination - from
	 1	 j
micturition to micturition - and consequently the amount of flush water
	
F	 s	
-
necessary to reduce the cross -contamination to an acceptable value. 
-Table 3-1
shows the results of tests with this USCS (unmodified) oriented with the
axis of the phase separator vertical ( in line with the gravity vector) and
	 #1
with the phase separator axis horizontal but with the system rotated so that
the phase separator outlet port was located in line with, at right angle to
	 `"#
c
or opposite to the gravity vector. 'able 3-2 shows the average value of phase
separator residual for the four orientations evaluated. Note that the
influence of gravity is significant and that a relatively small residual
can be anticipated under zero g conditions.
i
I
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TABLE 3-1
RESIDUAL VOLUME AS FUNCTION OF
USCS PHASE SEPARATOR ORIENTATION
hResidual
Phase
Test Liquid	 Separator
No. Input	 System	 Only Orientation(')
1 250 gms.	 30.0 gms.	 15.0 gms. 1i 2 250	 28.5	 14.5 1
3 250	 31.0	 14.7 1
t ' 4 2,50	 42.0	 7.0 2
5 250	 43.0	 11.0 2
'
t 6 250
	 44.5	 12.0 2
7 250	 46.0	 3.0 3
` 8 250	 7.5	 3.0 3
9 250	 15.5	 11.0 1
10 250	 15.5	 11.0 1
11 250	 11.5	 1.5 4
12 250	 19.5	 14.5 1
i 13 250	 21.0	 16.0 1
14 250	 18.5	 13.5 1
" 15 250	 17.5	 12.5 1
16 250	 24.5	 7.5 2
17 250	 25.0	 7.0 2
18 250	 23.5 -	 6.0 2
19 250	 15.0	 2.5 3
20 250
	 13.0
	
2.0 3
21 250	 9.0	 1.5 4
22 250	 8.5	 1.5 4
23 250	 16.0	 12.0 1
24 250	 18.0	 14.0 1
25 250	 16.0	 12.0 1
26 250	 24.5	 2.5 3
27 250	 24.5	 3.0 3
28 250	 16.5	 2.5 4
29 250	 16.5	 2.5 4
30 250
	 25.0	 3.0 3
31 25.0 gms.	 16.5 gms.	 2.5 gms. 4
(1) Orientation l - Phase separator rotational axis vertical.
" Orientations 2, 3 and 4 - phase separator rotational axis
horizontal; pump outlet at 12 o'clock, _9 o'clock and 6 o'clock
respectively (phase separator rotation CW at 400 rpm) viewed
from impellor end.
{
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TABLE 3-2
AVERAGE RESIDUAL VOLUME IN PHASE .SEPARATOR
Phase Separator
Orientation (1 ^	 Avg. Residual Volume
13.4 gms
2	 8.4 gms-. , k
3	 2.7 gms.
4	 2.0 gms .
(1)
See Table 3-1 for definition.
.• R
Thus for best simulation of zero g operation, orientation of the phase x
separator with the rotational axis horizontal and with the pump outlet
oriented between a 6 and 9 o'clock position (for CW rotation) is
recommended.	 A reduction in tubing ID and length is recommended for
reducing the residual yin the remainder of the system. 	 Note also that ^b
the accumulator has a preferred orientation for minimum residual when
operated under one g conditions.
3.1.2 Therriioelectric Cooling
The USCS, as originally designed, provided for cooling of the sample	 !.
_container via a coolant loop from an external source. The addition of
thermoelectric units was to make the USCS a self contained system with
minimal interface problems for flexibility of installation. Also to
r - ^r ;
	 alleviate possible microorganism growth problems in the system, cooling
was extended to include, in addition to the sample container, the phase
-6_
1=
F, •
	
._	 a
a"	 separator and accumulator and associated pump, valves and plumbing. To
ti
minimize the cooling load, the USCS components to be cooled (to 5 to 100C)
were relocated in an insulated compartment. Cooling was provided by
6 Cambion 801-1015-01 thermoelectric modules via forced air circulation.
Thermal energy was dissapated from the hot side junction using forced
air circulation. An estimated 72 watts of cooling is required. Design
'	 details are covered in Appendix 4.2. Subsequent laboratory testing of the
G
repackaged system (see Section 3.1.;3) verified the effectiveness of this
design.
3.1.3 System Repackaging
System repackaging was required to accomodate the addition of thermoelectric
cooling and reorientation of the phase separator and reduction in tubing length
needed to minimize the system residual. This was accomplished by increasing
the width of the unit from 8 to 15.5 inches, with all other external dimensions
remaining unchanged (see Figure 3-1) 	 Internally, the modified USCS is
divided into 3 sub-compartments. One compartment contains all the components
{	 involved in fluid handling, i.e., phase separator (less motor), accumulator,
i
pump and solenoid valves, urinal and sample container. This compartment is
thermally insulated and cooled by forced air over the thermoelectric element
cold junction heat exchanger. A second compartment contains the thermo
electric elements, hot junction heat exchanger and blower for heat rejection
;.;	 to ambient. The third section contains the electronic logic, signal
-7-
.&
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Figure 3-1. Repackaged USCS (Control Switches And
Volume Readout Meter On Top Surface;
Urinal And Sample Container Access
Doors On Side)
-13-
T
conditioning, power supplies, phase separator motor and other support
is
hardware.	 Overall system operation and performance capability did not i
change from that described in GE Report No. 70SD5414 (except for reduced
residual and additional cooling).
3.2	 ABSS Testing
The ABSS Urine Subsystem, described in detail in GE Report No. 74SO4208,
Part I, was designed as an advanced version of the USCS. 	 As such, many
of the design features from the USCS were incorporated into the ABSS Urine
i subsystem.	 Figure 3-2 shows the system block diagram; Figure 3-3 and
E; Figure 3-4 show the sampling and disinfect operating sequences. 	 A major
difference from the USCS (as modified) is that cooling of collected samples
e
only is provided in the ABSS Urine Subsystem. Also the ABSS Urine Subsystem
was designed to accommodate a six man crew (as compared to one for the USCS).y
3.2.1	 Introduction
The Automated. Biowaste Sampling System represents, in part, a highly sophis- #'k'
ticated approach to urine collection, volume measurement, and sampling.
	 If
kp7$
representative urine samples are to be obtained which. will exhibit values
...s
relevant to their real biochemical and microbiological content, the question
of sample integrity m	 b	 dl	
	
ust	 a ad ressed.
w	
^a
Thus, sample integrity was examined in a series of laboratory experiments
designed -to highligh t the following areas of biochemical /microbial	 interest:
f • - Evaluation of the Microbiological Sampler as a device/technique for
obtaining real-time, unadulterated urine samples for microbial
.^ analysis;
•	 Amount and effect .of the constant residual fluid volume in the ABSS,
i.e. loss of low-level constituents by dilution, or carry-over (cross-
contamination) from one sample to the next;
	 -
i
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INITIATE COLLECTION, SAMPLING, MEASUREMENT SEQUENCE t
(POWER ON; ELECTRONICS/THERMOELECTRIC ELEMENTS ACTIVE)
INSTALL CHEMICAL/BIOLOGICAL SAMPLE CONTAINERS
SET USER ID SELECTOR SWITCH r
INITIATE START (BLOWER/PHASE SEPARATOR ON)
REMOVE URINAL FROM HOLDER
MICTURITION/FILL MICROBIOLOGICAL SAMPLE CONTAINER
,. REPLACE URINAL
INITIATE SAMPLE
20 SEC. DELAY/BLOWER OFF
F RECIRCULATE (PURGE AIR OUT -2 PLUS ACCUM. CYCLES)
SMALL SAMPLE CHECK x
FILL CHEMICAL SAMPLE CONTAINER (5 ML)
^ ^3
'	 INJECT COMPENSATION VOLUME INTO POOL CONTAINER (5 ML)
I	 l PROPORTIONAL SAMPLING/EXCESS DUMP
50 ML CUT-OFF SIGNAL
PURGE URINE TO DUMP (3 ACCUM. CYCLES)
BLOWER ON
RINSE WATER INJECTION (50 ML)
RECIRCULATE AND DUMP (6 ACCUM. CYCLES)
BLOWER/PHASE.:SEPARATOR OFF
REMOVE CHEMICAL/MICROBIOLOGICAL +	 '
SAMPLE CONTAINERS
x ?
IF , SMALL SAMPLE
REPLACE CHEMICAL SAMPLE CONTAINER WITH 24-HOUR
POOL SAMPLE CONTAINERa
-	 INITIATE SMALL SAMPLE
FILL.SAMPLE CONTAINER (2 ACCUM. CYCLES)
PURGE URINE TO DUMP (3 ACCUM. CYCLES)
5
BLOWER
RINSE WATER INJECTION (50 ML) .
RECIRCULATE AND DUMP (6 ACCUM. CYCLES)
BLOWER/PHASE SEPARATOR OFF
REMOVE SMALL SAMPLE POOL/MICROBIOLOGICAL
SAMPLE CONTAINERS
i
Figure 3-3.	 Sampling Sequence (Not To Scale)
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INITIATE DISINFECT SEQUENCE
(POWER ON; ELECTRONIC/THERMOELECTRIC ELEMENTS ACTIVE)
PHASE SEPARATOR/BLOWER ON; DISPENSER AT RECIRCULATE POSITION
INJECT CONC. BIOCIDE
INJECT WATER (100 ML)
RECIRCULATE (3 ACCUM. CYCLES)
BLOWER OFF
30 MINUTE SOAK PERIOD
BLOWER ON
RECIRCULATE/PURGE*
INJECT 50 ML RINSE WATER
RECIRCULATE/PURGE*
INJECT 50 ML RINSE WATER
RECIRCULATE/PURGE*
INJECT 50 ML RINSE WATER
RECIRCULATE/PURGE*
INJECT 50 ML RINSE WATER
RECIRCULATE/PURGE*
INJECT 50 ML RINSE WATER
RECIRCULATE/PURGE*
BLOWER/PHASE SEPARATOR OFF
END OF SEQUENCE
3 RECIRCULATE FOLLOWED BY 3 DUMP CYCLES OF THE ACCUMULATOR
f_M' Or
• Response of the ABSS following bacterial contamination either from
infected urine or as the result of adventitious agents;
• Examination of the effect of the "disinfect- rinse " cycles on con-
taminating bacteria within the instrument.
t,	 3
3.2.2 M i crobiological Samplers ( See Figure 3.2.2-1, 2, 3)
The Microbiological Samplers (MS) were designed to allow real -time sampling
of the urine stream prior to contact with any of the mechanical interfaces
of the ABSS, and, therefore, before potential contamination. Testing was
structured to investigate the following basic areas:
Average amount of fluid retained in each MS;
Sterilization of the MS;
Sensitivity of the MS to test microorganisms; and
- Quantitative recoveries of test organisms from the MS,
3.2.2.1 Methods
3.:2.2,1.1 Average Fluid Volume
The Microbiological Samplers were tested to determine the average amount of
g
fluid retained in each of the stainless steel "cages" which held the wick.
Experience suggested that gauze squares were easier to standardize and insert
into the "cages" than the cotton.
	
-	 Gauze pads measuring 7 x 8 cm were'rolled up and substituted for the cotton
as a wick in the stainless steel "cages" within the MS. This was done because ^.
of the difficulty in inserting and removing cotton, wet or dry, and in
It standardizing the amount to be used.
i
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3.2.2.1.2 Sterilization
Sterilization of the complet Micro Sampler assembly was studied by inserting
a spore strip containing B. subtilis var. niger* spores into each wick and
placing the entire assembly at 121°C for 16 hours, 20.5 hours, and 24 hours.
At._each time period, duplicate assemblies were removed from the dry-heat
sterilizer, the stainless steel cage containing the wick and spore strip
placed into a tube of trypticase-soy broth, and incubated at 35°C. Tubes
were observed daily for one week. Those showing nor growth received a fresh
spore strip indicator and the tube was re - incubated at 35 °C and observed
c	 for growth.
P
1
3
.3.2.2.1.3 Sensitivity To Test Organisms 	 j
Sensitivity of the Micro Sampler to bacteria, i.e. ability to direct bacterial
contaminants in the urine, was studied by pouring 100 ml quantities of various
aqueous dilutions of E. coli (ATCC #15144), representing contaminated urine,
into a urine receiver-cup containing a sterile sampler. Programmed bacterial
levels ranged from 106 organisms/ml to < 10- 2 organisms/ml. After exposure,
all samplers (cage and wick only) were incubated in trypticase-soy broth at
35°C for one week. Cultures not exhibiting growth at the end of the week
were inoculated 'directly 'with one drop of the original E. coli culture, and 	 T'
re-incubated.	 ^rV'
t
3.2.2.1.4 Quantitative Recoveries Of Test Organisms From MS
x^
The capacity of the samplers to provide quantitiee recoveries of test organisms
was studied. Fifty ml aliquots of normal urine containing E. coli (ATCC #151.44)
at ti 106
 organisms/ml were poured over each of the sterile samplers inserted
t.
* Obtained From The Wilmot-Castle, Rochester, N. Y. 14602, Lot #B-24
	
'q
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withing the urine cup of the ABSS. 	 After each sampler had been exposed, the
stainless steel "cage" containing the gauze / bacteria was deposited into a
flask containing 48 ml of sterile trypticase-soy broth and then placed on an
Eberbach shaker set to operate at N 50 excursions/minute for 15 minutes.	 In
k
^w
one case, duplicate flask-samplers were shaken for 30 minutes. This solution
of broth and bacteria was considered a 1:25 dilution. 	 Another 1:4 dilution
was made in distilled water to give a 10- 2 dilution.	 Additional 10-fold
dilutions were made to allow a titration of 3 replicate plates/dilution in
.^.	 trypticase-soy agar.
3.2.2.2 Results Of The Assessment Of The Microbiologi cal 'Sampler (MS)
u.
3.2.2.2.1 Average Fluid Volume R etained By The MS
Average retention of fluid in these wicks was determined to be 2.2 ml/wick
^,,,
	 after pouring 14, 100 ml increments of water through replicate MS's prepared
with gauze wicks.
3.2.2.2.2	 Sterilization Of The MS
Results of the long dwell-time, lower dry heat sterilization of the Samplers
are shown in Table 3.2.2.2.2. As indicated in the Table, 16 hours at-121°C
was sufficient to sterilize the stainless steel cages (supports) and wicks.
3.2.2.2.3	 Sensitivity Of MS To Test Organisms
E.	 co'li ' (ATCC #15144) vias used to produce varying amounts of viable organisms
in 100 ml quantities to simulate contaminated urine.
	 Each of these dilutions
-17-
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xTABLE 3.2.2.2.2
RESULTS OF VARIABLE DWELL TIMES AT 121°C
USING SPORE STRIPS OF B. SUBTILIS, VAR.
NIGER1 AS STERILITY CON^R LL INDICATORS
FOR STERILIZATION OF THE MICROBIAL SAMPLERS
Results Of _Incubation 2
 At 35°C
Sterilizing	 Spore Strip
Samples	 Time	 24 Hours	 1 Week	 Add - Back
1	 16	 Hours	 0	 0i
	
+
2	 16 Hours	 0	 0
3	 20.5 Hours	 0	 0	 +
4	 20.5 Hours	 0	 0	 +
5	 24 Hours	 0	 0
6	 24 Hours	 0	 0
Spore Strip	 N/A	 +	 F	 +t	
Control
,j
i	 Obtained From Wilmot Castle, Rochester, N. Y., 14602, Lot No. B-24
2 Incubation Medium Was Trypticase-Soy Broth
0 = No Discernable Growth
+ = Growth '	 R
{
were poured over the sterile MS wicks which had been inserted in the urinal
cup. After exposure to the test dilutions, each wick was placed into a flask
containing sterile trypticase-soy broth and incubated at 35°C for one week.
Y
R
Results are displayed in Table 3.2.2:2.3.
1
^^ r
oF
TABLE 3.2.2.2.3
GROWTH OF BACTERIA CAPTURED BY MICROBIAL SAMPLERS I
:FOLLOWING EXPOSURE TO 100 ML DILUTIONS OF E. COLI
POURED THROUGH THE WICK
Approx. No.	 Theor. Total	 Growth Afterz
Dilutions -	 Of E.coli/ml	 No. Organisms	 1 Week At 350C
Tested	 In DTTuffon	 Exposed To Wick	 (Duplicate Samples)
10-2 	3 x 10 6 	3 x 10 8 	+
p
f 10-4	 3x10`'	 3x106
10-6	 3 x 102 	3 x 104 	+
+',
10- 7 3 x 10 1 	3 x 10 3 	+
10- 8 	3	 3 x 102 	+
10- 9 	0.3	 3 x 10 1 	+
03
`
1,0-10	 0.03	 3 x 10°	 0
0
1	 E.coli Culture.ATCC #15144
2
	
TRUFation Medium, 'Trypti case-Soy Broth
i.. 3	 After 48 Hours Incubation, Broth Turned Green In Color, No Evidence Of Growth
^i
m. As shown in the Table, the sensitivity of the Samplers to capture of, and
a
compatibility with, microorganisms was demonstrated with urine samples
-containing total numbers of E.coli as low as 30 (0.3 organisms/ml).
	 These
-results were obtained following immediate application of the wick to an
^( appropriate growth medium and temperature; no attempt was made to hold the
exposed wicks at refrigerator or freezer temperatures before assaying for
growth.
k
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3.2.2.2.4 Results Of quantitative Recoveries Of Test Organisms From The'MS
Results of the quantitative recovery studies are tabulated in Table 3.2.2.2.4.
TABLE 3.2.2.2.4
QUANTITATIVE RECOVERY OF E. COLI FROM MICROBIAL SAMPLERS
FOLLOWING 15 AND 30 MINUTE CITATION* - SAMPLERS EXPOSED
TO 50 ML ALIQUOTS OF URINE CONTAINING 10 6 ORGANISMS/ML
Average Titer Of Duplicate Samples
Trial No.	 15 Minute	 30 Minute
1	 3x 10 5	2 x 106 "
2	 2 x 106
	3 x 106
3	 2 x 105
4	 2 x 105
Control
	
5 x 106
1
*Samplers Shaken In Eberbach Shaker At 50 Excursions/Minute
As shown, after 15 minutes of shaking the amount of E. coli recovered was
essentially 1 log lower than the control; with 30 minutes shaking, recoveries
	 x:
approached the levels of the control. Additional testing would be required
4
to establish the optimum degree of agitation, medium, time, and procedure,
but these preliminary data indicate that the use of the Microbial Sample for
	
a
the quantitative recovery of microorganism from urine, is feasible.
t
r:
f
	
a	 .
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The studies reported here demonstrate the Microbial Samplers as presently
configured _ provide both a sensitive and quantitative means of obtaining a
real-time urine sample for microbiological testing.
On the other hand, operational experience with the samplers has produced the
following comments:
e Manipulation of the samplers - implacement, recovery, removal of
the wick, etc. - was judged to be awkward; really needed "3 hands"
to operate adequately.
The potential risk of contamination with urine (and therefore bacteria)
to the operator and/or the spacecraft envirr,,nment was considered high.
°° •	 Use of the sampler required excessive time and involvement on the
W pant of the operator.
3.2.2.4
	
Recommendations
In view of these conclusions it is recommended that the following actions
be considered:
u k+^ •	 Development of a modified form of the MS which significantly reduces
the potential contamination risk. 	 Adaptation of various commercially
available urine sampling devices, e.g. Smith, Kline & French Labs
Clinicult, could be accomplished with minimum cost to NASA.
e	 Incorporation of a quantitative capability within the design of the
ar MS so that all information can be obtained more quickly, safely and
conveniently.	 Again, adaptability of commercially available products s
could be accomplished.
3.2.3	 Chemical Cross-Contamination Studies (See Figure 3.2.3-1, 2, 3)
3.2.3.1	 Methods
i
3.2.3,1.1	 Baseline Conditions
The following were considered baseline conditions for these experiments.
ur
A ^
1
L mss;
	 t E	 '
r
Figure 3.2.3-1. ABSS-General Test
Configuration
Figure 3.2.3-3. ABSS-Rinse Water Reservoir
And Cold Sterilization
(Filtration) Arrangement
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Fi gure 3.2.3-2. ABSS-Proportional
Sampling Syringe
(Accumulator) And
Power Supply
PIP
1
-+	 f
1
i
Figure 3.2.3-4. ABSS-t"ale/Female urine
Receiving Cup And
Electronics Packages
bw
I	 I	 I	 I	 l_ _ 1
	
_^_
This was imposed in order to reduce the effects of some variables, e.g. male
versus female urine on the biochemical studies:
• All urine employed for these tests was male, freshly collected
(within two hours) from a single micturation;
e Minimum volume employed was 120 ml;
• Samples of each urine were tested for presence and level of potential
microbial organisms;
e Volume of urine, both input and output, was determined by weight;
• No attempt was made to disinfect or otherwise decontaminate the
fluid pathways within the ABSS before start , of the tests.
3.2.3.1.2 Residual Volume - Direct Measurement
The constant fluid volume which remained within the-fluid pathway of the ABSS was
i
measured by:	 1) draining and air-drying where possible, all fluid lines, phase
separator, and valves.	 2) adding a known weight of water (1 gm = 1 ml); and
3) direct measurement by weight of the amount recovered. 	 The difference between
the two weights was considered to be the residual volume (See Figure 3.2.3.1.3).
3.2.3.1.3	 Residual Volume - Indirect Measurement
Quantities of an aqueous solution of Rhodamine B*, a highly water-soluble dye with
a known absorbance value at 550 nm, was introduced to the ABSS which had been
thoroughly flushed with water, i.e. zero optical density. 	 The resulting dilution
of the effluent dye samples as measured through the change in optical density (OD)
and subsequently, the volume of water necessary to produce that change could be
calcuated (See Fiqure 3.2.3.1.3).
*Stock dye solution was prepared by diluting a saturated aqueous solution of the
w
dye to a final dilution of 4 x 10' 3 (1/4000).
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in t out t
2. DFs O
_D^
	ODc 	V 	 Volume (ml) of fluid involved
x
3. DFd = ODd	 DF,= Dilution Factor
	
ODc	 OD!='Optical Density of appropriate sample
4. RV = Vs 	 ( Vs x DFs)	 %R = Percent Recovery of fluid derived
s	 DFs	 from either s or d
5, RVd = Vd - ( Vd x DFd)	 d = Dump	 Port fluid
DFa
s	 Sample Port Fluid	
E.
wk
6. %R = Vs x 100
	
s Vt	 c = Control fluid
t = Total fluid involved
7. %Rd 	Vd 
_
x 100
	V t	 CDF = Combination Dilution factor (weighted
for proportional vol. of fluid invol'ved).
8. CDF
	
(DFs x %RS ) + (DFd• x %Rd)
TV
z
r
Figure 3.2.3.1.3. Formulae Used In Calculation Of Residual Volume
Direct And Indirect
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1	 RV=V -	 -V
	
RV = Residual Volume (ml)
j
4
3.2.3.1 .4 Phosphate (Inorganic Phosphorus)
The phosphorus content of each urine (pre-use aliquot and effluent sample) wasi
determin€d by a spectrophotometric method derived from Taussky.* The complete
r
	 method is presented in Appendix 4.1.
3.2.3.1.5 Dip Stick Analysis
The Ames Multistix dip-and-read test strips were used to provide a range of seven,
semi-quantitative urine parameters. These were: pH, protein, glucose, ketones,
urine bilirubin, blond, and urine urobilinogen. _Color comparator charts were furnished_
with each bottle of dip sticks along with reading - time restrictions for each test.
In order to study th,:y sample to sample effect of a high concentration of any single
constituent, a concentrated solution of hemoglobin was prepared by mixing equal
quantities of freshly drawn venous blood and distilled water. The resulting lysis
i of the RBC's produced a hemaglobin solution which was able to elicit a positive 	 j
response on the Multistix blood-reagent par up to a dilution of 10 5 . This solution
was then used to add a fresh urine input ( 1/100 diln.) in order to study potential 	 x
1
chemical carryover (cross-contamination) within the ABSS`.
3.2.3.2 Biochemical Testing Results
M	 3.2.3.2.1 Residual Volume - Direct Measurement
Four separate measurements with a "dry" instrument, i.e. air drying and disassembly
as required, indicated that the average residual volume of fluid which would con- 	 x;3
sistently remain within the fluid pathways ofthe ABSS was 18.1 ml + 0.3,. This
amount was used in calcuating theoretical dilutions of subsequent fluid inputs to
the ABSS.
* Taussky, H.H. and Shorr E. J. Biol. Chem. 202; 675-85 1953
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3:.2.3.2.2	 Residual Volume - Indirect Measurement
Table 3.2.3.2.2 summarizes the results of the experiments to determine the residual
q
Volume by indirect measurement, i.e. dye dilution technique. 	 The percent dilution
was. calculated from the ratio of the optical density (OD) of the effluent to the
orignial OD.	 The volume of fluid required to produce that percentage dilution can
then be calculated (See Figure 3.2.3.1.3; 72, 3). 	 Examination of the data suggests
that the accuracy of the technique increases as the input volume increases.
The data also highlights the regular differences which occur between the calculated
dilutions for the Sample Port effluent and those for the Dump Port. 	 This suggests
that the mixing of the residual fluid with each input fluid may not be homogenous.
This is demonstrated by comparing the calculated percent dilution derived from the
Sample Port data; as the volume of input fluid increases, the calculated value
'	 becomes closer to the theoretical value.
3.2.3.2.3
	 Residual Volume - Effect On Urine Phosphorous -.
As-a part of a one-week experiment to study biochemical responses of the ABSS under
actual use conditions inorganic phosphorus was assayed in an attempt to demonstrate
the effect of the residual fluid on the chemical constituents in urine samples obtained
from the Sample Port. 	 Since routine operation of the ABSS included a water rinse of
80-85 ml following collection and distribution of the urine, it was assumed that a
.	 large portion of the residual fluid. would be composed of the rinse water.	 Therefore,
assays of phosphcrus within urine aliquots obtained from the Sample Port should °-
demonstrate reduction from the control (input sample) as a result of this dilution.
t	
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TABLE 3.2.3.2.2
i
RESIDUAL VOLUME - INDIRECT MEASUREMENT
PERCENT CHANGE IN OPTICAL DENSITY OF
RHODAMINE B AT 550 NM AS AN INDICATOR
OF THE DILUTION EFFECT OF THE RESIDUAL
VOLUME ON VARIOUS INPUT VOLUMES
IN-PUT FLUID OUT-PUT FLUID
AVG.
VOL. 4
THEORETICAL	 SAMPLE
1
PORT DUMP PORT
L
% DILN OF
3COMBINATION
E
x DILN	 % DILN
-
INPUT % DILN	 % INPUT
-
F 90 ML 83.3	 80.2 11.2 79.2	 88.8 79.4
150 ML 89.3	 88.5 1.1:3 86.1	 88.7 86,3
300 ML 94.3	 95.6 11.5 95.8	 88.5 95.8
t;
r.
1 - Based on the avg. vol. added and the 18 ml	 residual	 fluid volume.
a
2 - Calculated from measured Volume of -original in-put delivered to each port.
3 - Calculated from Sample and Dump Port data and weighted for proportional
volume.
k 4 - Avg. of _a minimum of three replicate determinations/vol. level.
j
i
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Ten consecutive urine samples from the ABSS and their corresponding controls were
assayed for inorganic phosphorus content according to the method described by
Taussky (See Appendix 4.1). Table 3.2.3.2.3 which summarizes the effect of residual
fluid on P content, indicates a consistent reduction in the P found in the urine
samples from the ABSS vs. the P in the control urine.
A Student's "t" test for non-paired experiments was performed on the data.
	
The
analysis demonstrated that the mean of the differences between the theoretically
determined percent dilutions and those calculated from the experimental data was
not significantly different from zero.
	 Therefore, it was concluded that urine
chemical constituents were diluted by the residual fluid.
	 The magnitude of the
dilution which occurs would appear to be dependent upon:
	 --
•	 The proportion of the residual fluid composed of rinse water versus.x
the previous urine input.
•	 The level of the chemical constituent from the previous ur ge to be 1
monitored.
•	 The sensitivity of the assay techniques.
3.2.3.2.4	 Residual Volume - Effect On Dip Stick Analysis
Of the seven routine urine constituents incorporated within the Multistix dip-and-
a
read test stips, no naturally occurring abnormal levels were demonstrated by any of I
the urine used in the experiment. 	 To study the effect of abnormally high chemical }	 ,
constituents, a hemaglobin reagent, prepared from fresh venous blood was added to
a single urine input sample (run #53) at approximately a 1:100 dilution, and inserted "I	 r	
l
into the instrument.	 The sample aliquot normally delivered by the ABSS demonstrated
vs
,complete sensitivity (3+) to the presence of the high concentration of hemaglobin.
r^
,.	 a _:
Two more urine inputs of 330 ml and 141 ml (runs #54 and 55) were introduced to the e
ABSS after 24 and 48 hours,_ respectively. 	 The sample obtained from Run #55 was still
7.
capable of demonstrating a minimum sensitivity (±) to the hemaglobin test pad on the
-28-
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TABLE 3.2.3.2.3
SUMMARY OF URINE PHOSPHORUS DILUTION
VALUES FROM CONSECUTIVE URINE SAMPLES
FROM THE ABSS SAMPLE PORT
INPUT	 THEORET.	 % DILN. 0
RUN NO.	 VOL.-ML	 % DILN 1	P DETN'D
54	 329	 95	 92
551	 141	 89	 !	 95
56,
	 208	 92	 103
57	 NO	 NO	 NO
58	 193	 91	 93
59' 390 96 89
60' 133 88 89
61' 122 87 90
62 314 95 75
63 333 95 86
},ri
wk
fi
dipstick. Considering the water rinses of approximately 85 ml which were routinely
associated with each input sequence, plus the two subsequent urine inputs, the total
dilution effect on the hemaglobin reagent was calculated to be approximately 3000 -
fold. The original hemaglobin reagent was assayed at a titer of 10 5 ; the dilution
from the urine input (run #53) of approximately 1:100 reduced this titer to 103,
making the total calculated dilution effect within the instrument to be 3 x 103
or 1:3000. Thus, the carryover from the original abnormal hemaglobin was detectable
in the sample after two additional urine inputs through the ABSS confirming, at least
by the conditions of this test, the potential for cross-contamination from sample to
sample.
The extent of this cross-contamianti on is dependent upon two variables: 1) the level
or concentration of the biochemical constituent, and 2) the sensitivity of the assay
technique for the constituent. Therefore, it would appear that the ABSS user-
sequence should be consulted when abnormal amounts of biochemical constituents are
detected in sample pools obtained from instruments.
3.2.3.3 Conclusions - Biochemical Testing t
,s
Results of the preliminary biochemical testing phase have demonstrated the following:
1. A consistent residual volume of approximately 18 ml remains in the AuSS
during normal operation; x
2._ The residual volume causes dilution within the urine aliquot derived from 9
the sample port;.and
3. Carry-over of chemical constituents (cross-contamination) from sample
to sample does occur.
Therefore, the following conclusions can be drawn:
a. r
• Potential carry-over of biochemical constituents from one urine input
to the next, an uncontrollatle variable, negates the use of proportional
urine samples from the ABSS for research quality, bio-medical investigations.
• -Arbitrarily, if the residual volume was reduced by one half, thereby
reducing the dilution effect, the ABSS could provide adequate samples for
`	 - routine clinical level testing, i.e. crew-health monitoring.
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Note - Although not addressed in this Section, the presence of reservoirs
of microbial _contaminants would also negate the use of the ABSS for
either use. Data presented in Section 3.2.4 confirm the presence
of this contamination.
3.2.3.4 Recommendations - Biochemical Testing
Future designs for urine sampling hardware should incorporate the following:
1. Shorter fluid pathways (reduces residual fluid);
2. Elimination of dead-ends, crevices, etc. which can impinge and hold fluid;
3. Reduction of complexity, i.e. elimination of valves where possible, and
c-apability for "plug" flow.to avoid mixing one urine with another. This
would allow elimination of the water rinse incorporated within each cycle,
K	 thus reducing another interface, including reservoir, valves, lines, etc.
i'
It is recognized that incorporation of these suggestions may reduce the degree of
automaticity and/or increase operator involvement to a slightly higher level.
.,	 However, it is expected that the overall improvement in sample integrity will
A_
;'	 offset the disadvantages.
T	 3.2.4 Microbiological Response: Betadine*/Disinfect Studies
a^
3.2.4.1 Objectives/Discussion
Experience with the ABSS during the biochemical, cross-contamination study,
, F _	 i.e. carryover of hemoglobin, suggested that microbiological contaminants
would behave similarly. Therefore, a specific objective of the microbiological
assessment was to study the behavior of adventitious urine microorganisms,
as well as added microbial markers (contaminants), both from the urine sample
aliquot (sampling mode), and from the waste urine tank. It was of interest
; 1M	 to determine for example, if successive, urine inputs would significantly
{i
^t
Traaemark for Povi one-Io ne distributed b y the Purdue-Frederick Uompany,
Norwalk, Conn. 06856.
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reduce or at least lower the viable bacterial population level within the
ABSS.	 Some of the factors affecting this question are summarized below:
•	 Type of contaminant in each urine input (bacteria or fungus, hardy
or labile,potential variety of microbial mix);
•	 Population size of the contaminant(s);
e,	 Internal structure of the fluid pathways which would promote pockets
or reservoirs of contamination	 e.g. crevices	 dead-ends	 etc.;
•	 Volume and frequency of the urine inputs.
Because thorough investigation of all factors was beyond the intended scope
of 'these studies, the total effect was measured primarily by assay of the
viable microbial titer of successive urine samples delivered by the ABSS, and
of selected samples obtained from the waste urine tank.
Another objective of these studies was the investigation of the efficacy of
Betadine as an effective agent for both disinfection of the ABSS, and stabili-
zation of -microbial growth within the urine waste holding tank. 	 It is
necessary to establish the concentration of Betadine, in terms of available
iodine required to provide effective destruction, or at least inhibition p
(stabilization),of microbiological contaminants found in the urine inputs.
Still another objective was the investigation of the efficacy of Betadine
as a disinfectant applied on a use-by-use basis in a simulation of the Waste
Collection System (WCS) as proposed for operation )n the Space Shuttle
;
Program.	 Because there is no requirement to measure ,urine volume, provide,
r^
a proportional sample, or a water rinse cycle, the WCS imposes simpler, less
sophisticated operational demands than the ABSS. 	 Disinfection in the WCS
will be effected by insertion of uniform amounts of Betadine with each urine
-32-
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input.. Therefore, for these tests the ABSS was modified mechanically
(described below) so as to simulate, as closely as possible, the operational
characteristics of the WCS and the subsequent effects of the Betadine on the
collected urine.
3.2.4.2 Experimental Outline And Base
Experimental data for those objectives described above was derived from a
series of 3 laboratory tests as follows:
mss,
1. Effect of frequent urine inputs on the microbial population within
'	 the ABSS without operation of the "Disinfectant" cycle
Total Elapsed Time = 12 days
- Total Urine Inputs = 87
Total Urine Volume =,17.7 liters
2. Effect of a single Betadine rinse on the microbial levels within the
ABSS (as determined from effluent samples) -
- Total Elapsed Time = 3 days
- Total Urine Inputs = 20
Total Urine Volume = 3.1 liters
3. Effect of use-by-use addition of Betadine to a urine collection
system which simulates the WCS, i.e. no sample mode, no water flush
Total Elapsed Time = 4 days
- Total Urine Inputs = 24
Total Urine Volume = 4.8 liters
Experimental conditions which were considered as baseline are listed below:
e All urine was collected from a single micturation and used within a
maximum of 2-hours;
• Male and female urine was employed;	 --
• All urine inputs were assayed for level of pre-existing microbial
E	 =fit	 population;
5	 • Rinse water used by ABSS was sterilized through use of in-line
membrane filters (0.22u );
	
r
• Volume of rinse water employed was adjusted to ti 70 ml/rinse following.
routine urine inputs, and 100 ml with the "Disinfect" cycle;
-33-
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• ABSS was decontaminated before each experimental- series with 2%
peracetic acid;
e Volume of every input urine was determined by weight; and
• ,^r-ce each operational day, 10 6 organisms/ml of E.coli was added, via
ut4ne input, for use as a marker organism in assaying experimental
effL-cts.
3.2:4.3 Methods And Procedures
Detailed procedures and materials used for each list sequence are reproduced
in Appendix 4.1. The following represent general methods applied to each testa
Urine Pre-existing Microbe Assay 	
F
Replicate 1 ml quantities of each urine were incubated in trypticase-sov
	 w.
agar lates at 35°C. In cases where colonies were too numerous to cuunl
(TNTC^, the count was arbitrarily recorded as 103. 	 In cases where more
than one colony type was present, no attempt was made to separate the
two types in the count.
Sterile Rinse Water
A stainless steel pressure can was used as a reservoir to hold the
distilled rinse water. Sterility of the water was achieved by passage
through a 142 mm membrane filter of 0.22 micron average pore diameter
held in a Millipore stainless steel holder. A pressure of 17 psi (879
mm Hg) on the reservoir tank was sufficient to insure a final flow rate
into the ABSS of 70 ml per rinse (normal rinse cycle), and during the
"'Disinfect" cycle, 100 ml of water.,
Decontamination of ABSS
A mixtura of 2% Peracetic Acid and Naccanol surfactant was used as the
agent to decontaminate the ABSS fluid pathways before each experiment
(See Protocol for exact formula and preparation). Five hundred ml_._
quantities of the 2% acid were circulated within the ABSS and allowed
to stand for 30 minutes. Two of these treatments were followed by 6-7,
500 ml portions of sterile, distilled water rinses - or until the pH
of the effluent returned to 6.5 or higher. Sterility tests on neutral
effluents from the sterile water rinses indicated that microbial, con-
tamination was not eliminated by this procedure	 Levels of growth in
trypticase-soy agar were about 10 1
 colonies/ml. No further effort
	 `-
was made to eliminate this residual contamination.
z
, s
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Volume	 Urine Inputsof 's
i
All micturations were collected in clean, 450 ml plastic containers
which exhibited a uniform tare weight. 	 Each urine was weighed before
addition to the ABSS.	 The final volume was regarded as the total less
j the container tare weight. 	 (Note - for these purposes, 1 gram of urine
{ was considered to be equal 	 to 1 ml.)
1 Addition of E.coli as a Marker Organism
E.coli	 (ATCC #15144) was incubated for	 18 hours at 35 0C in a 500 ml
flask containing 50 ml of trypticase-soy broth.	 Inoculum was 1 drop of !
a previous 18-hour culture held at 4°C.	 A fresh culture was prepared
for each operational day. 	 The titer of each 18-hour culture was assumed
to be approximately 5 x 10 8 .	 Therefore a 1:100 dilution was arbitrarily
made in each urine to produce a final titer of E.coli of approximately
5 x 10 6 .	 Actual counts were made on each "loaded urine when the effluent
sample was assayed.
Titration of Effluent Samples and Urine Pool Samples
I In order to judge the effect, if any, of the experimental conditions,
effluent samples and urine-pool samples were assayed in Eosin-Methylene-
g{r Blue	 EMB) Agar which exhibits dark red centers with the E.coli	 (Marker).
WA Because other microorganisms could be inhibited by the EMB agar, parallel
titrations were also performed in trypticase-soy agar to obtain a total
microbial count.
Modification of ABSS for WCS Simulation
t The ABSS was modified mechanically to simulate the operational character-
istics of the WCS. 	 Fluid lines directly off of the proportional accumu-
lator were altered to feed directly to the urine pool, thus by-passing
'
the normal	 recirculate, sample, flush, and solenoid valve sequences.
- Rinse water was also turned off.	 To simulate addition of the disinfectant,
15 ml of full-strength (10%) Betadine was added to each urine input
simultaneously with the insertion into the instrument.
	 The total amount
of;Betadine added was calculated on a projected daily frequency and
I volume so as to provide a minimum of 600 ppm of free IZ in the urine pool -
} at the end of each operational day. 	 The net result of this modification
was significantly faster processing of the rinse through the instrument.
Also, with the substantially reduced fluid pathway, the peracetic acid
., rinse was significantly more successful in reducing contaminants:
	 After
two acid rinses and 5 sterile water rinses the viable count was < 1
organism/ml.
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Betadine Concentrations
Betadine is the tradename for a mixture of 10% iodine complexed with
polyvinyl pyrrolidone, which provides 1% available or free I 2 . Therefore,
at full-strength there is 10,000 ppm (10 gram/l. or 10,000 mg /1) available
I 22 . All calculations as to initial and final iodine concentrations in
tie Betadine reservoir or in the urine pool were based upon those figures.
It was assumed that the providone - I2 complex behaves like a weakly	 wa
dissociated salt, i.e. additional iodine is released as the free iodine
is consumed.	 a
3.2.4.4 Experimental Results
3.2.4.4 . 1 Effect Of Sequential Urine Inputs On Microbial Population Of The ABSS
E.coli was added to an early urine input ( 1st or 2nd) once each operational	 .y
day at a level of ti 10 6 organisms /ml. This was considered representative of
a pathological level in a possible urinary infection, and therefore served
as a marker organism to study the passage of a potential bacterial contaminant
through the ABSS or its impingement within the fluid pathways. Since normal
urines generally contain variable quantities of microorganisms (< 10 0 to 10 3 ),	 ^a
it was necessary to determine if subsequent normal urine inputs, with low 	 r
levels of bacteria, would flush out the marker, or become impinged within 	 ^a
-	 j
the fluid pathways and compete for nutritional dominance (See Section 3.2.4.2-1).
1
Decontamination of the ABSS with 2% peracetic acid was attempted before the
start of the test; low levels of microorganisms were still recoverable in
the effluent, even after 2 courses of treatment with the acid (,^, 102
 organisms/ml).
For this study, selected samples of the urine effluents were assayed in both
EMB and trypticase-soy agar to determine the levels of the marker (E._coli)
and any other unidentified microorganisms which were recoverable. The test
covered 7 operational days but encompassed a 12-day span, i.e. 3-day weekend
between 3rd and 4th operational days, with a total of 87 urine inputs (average
12 per day) averaging 203.6 ml per input (17.7 liter total).
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Table 3.2.4.4.1 presents the experimental results. It is apparent that the
frequent urine inputs were not able to flush out the marker organisms, but
were also contributing additional microorganisms to the system with subsequent
multiplication and maintenance of titers at 107 to 108 . This strongly suggests
yt` that the fluid pathways (including phase separator and solenoid valves) contain
abundant crevices and dead-end spaces which can serve as excellent reservoirs
for bacteria.- In addition, the inability of 2% peracetic acid to reach and
lyre the contaminants lodged within the ABSS supports this conclusion.
Additional examination of the data suggests that the 107 per ml level probably
represents a maximum titer, at least for the organisms in this study which
were successful. Factors such as volume, nutrient supply, and mixof organisms
are interacting limitations.
Additional- information was also gathered from this experiment: The effects
of accumulating quantities of urine, as in a normal use-condition, on
the multiplication of the microbial population and corresponding production
t
w
	
	
of gas in the urine waste tank was determined. At the end of each operational
day, all lines from the ABSS were closed off with pinch clamps, and the air
space above the urine was connected to a water manometer and allowed to
strand overnight at room temperature (ti 16 hours). Each morning the pressure
was recorded and the clamps removed, before sampling of the urine tank, and
before the first urine input of the operational day.
}	 Results are reported on Table 3.2.4.4.1-2. As shown.., titersof both the
M,.
	
	
marker ( E. coli) and .other contaminants. quickly reached a level of 107
organism/ml (by day 2), and remained there. At the same time, the urine
-37-
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TABLE 3.2.4.4.1-1
EFFECT OF SEQUENTIAL URINE INPUTS
ON MARKER ORGANISM (E.COLI) AND
ADVENTITIOUS ORGANISMS
-FW WITHIN
FLUID PATHWAYS OF ABSS (SAMPLE EFFLUENT)
DAY
-URINE INPUT DATA URINE SAMPLE PORT ALIQUOT S
 COUNT/ML
TOTAL
TOTAL DAILY AVE. DAILY '' FIRST SAMPLE SECOND SAMPLE FINAL SAMPLE
N0./DAY VOL. VOL./INPUT
(ml) (ml) E.COLI1 OTHER2 E.COLI OTHER E.COLI OTHER
1 15 3312 214 4 x 106 1 x 105
4 x 105 < 103
4 x 1 0 3 <	 101
2 14 2287 163 2 x 106 1	 x -1-03
5 X 106 < 104
7X104 4x 104
3 10 2428 243 > 104 > 104
8x107 3x106
1 x 105 9 x 105
4 12 2431 203 4 x 106 9 x 106
8X 105 3x 106_
1 x 105 2 x 105
5 14 2872 205 NP > 106
3 x 106 1 x 107 -
NP 5 x 105
6 12 2471 206 3 x 105 1 x'106
1 x 107 4 x 107
3 X 105 1 x 106
7 10 1912 191 NP 2 x 108
1 x 107 4 x. 107
1	 x 106 9 x 106
t PIN
1 - E.coli	 (ATCC 15144) at N 106
 organisms/ml added in second urine input each day
,..
except 1st and 4th day). r'
2 - EMB Agar used to differentiate marker organism (E.coli) from naturally occurring
contaminants, £
3 - ABSS fluid pathways decontaminated with Peracetic Acid before start of test period.
NP = Count not possible, probably due to competative inhibition with other contaminants.,
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TABLE 3.2.4.4.1-2
EFFECT OF SEQUENTIAL URINE
INPUTS ON GAS PRODUCTION AND
MICROBIAL TITERS WITHIN THE
URINE WASTE POOL
1
-_
URINE INPUT URINE POOL
P"ZSSURETOTAL
DAY DAILY	 UMUL. INPUT COUNT/ML1 CHANGE(CM
VOL.	 VOL. NO. E. COLI OTHER H2O2)
:Two 1 2430/2430 12 0 3 x 108 - 2.3
2 2872/5302 14 1	 x 107 >	 10 8 -19.7
3 -54.52471/7773 12 1	 x 108 5 x 108
4 1912/9685 10 2 x 108 2 x 108 ND
i
E;
i Samples for counts were drawn 24 hours after initial input for days 1-,
t. 2 and 3,and 72 hours after initial input for day 4.
n, 2- Pressure was recorded from last input of day to first input of the next day
(16 hours).
.E
t
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waste tank exhibited an ever increasing negative pressure from the endogenous
respiration of the accumulated quantities of microbial contaminants. The
urine reservoir consisted of a glass jug of ti 16 liter capacity; by the end
of day 3, the jug was approximately 0.6 full. This serves to explain, in
part, the negative pressure of ,, 21 inches of water exhibited by the urine
pool'; i . e. reduced airspace and increased volume of urine / bacteria would
tend to pyramid the effects of the withdrawal of gas from the available supply.
The data underlines the potential risks in untreated urine waste pools, since
the factors which tend to control the potential results, e.g. quantity, mix
of organisms, etc. are essentially uncontrolled variables.
3.2.4.4.2 ABSS/Betadine Disinfect Studies
3.2.4.4.2.1 Introduction
The speed with which the adventitious microbial contaminants became established
within the ABSS and the multiplication level they attained, as demonstrated
by the previous experiment ( see Table 3 . 2.4.4.1) suggests the need for a	 -
daily purge with an appropriate disinfectant. Betadine has been recommended
as a potential candidate.
I n structuring the Betadine -disinfection experiments, the underlying theory
was that to be successful, the disinfectant was not primarily required to
kill/inactivate all the microbial population, but merely to maintain the
contaminants at an acceptable level, i.e. stabilize. This was especially
true with respect to the urine tank which is a potential reservoir for a
y ^	 wide range of organisms. To the extent that the disinfectant -rinse can
reduce the pockets of contaminants within the ABSS, the long -term growth	 ^ Y
potential in the waste reservoir could be reduced.
4
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3.;2.4.4.2.2 Effect Of Betadine On Microbial Contaminants Within Fluii
n_A.L.._.._ nr t _ Her
An attempt was made to study the effect of the disinfectant on the level of-con-
taminants within the instrument through the action of Betadine. The water
flush of 70 ml following each urine input'will produce a dilution of the
18 ml residual urine within the fluid pathways, which then results in a
theoretical urine concentration of - 20%:
18 ml urine (residual)
f 18 ml + 70 ml H2O rinse x 100
	 20% (approximately)
f.
	
ik'"tM"	 i
With this reduction in the quantity of protein (organic material). The
Betadine was expected to be capable of antimicrobial activity against the
4 -k
indwelling contaminants, thus reducing the potential cross-contamination
effect on the effluent urine samples. The concentration of Betadine to be
delivered to the fluid pathways (( phase separator, lines, etc.) was set at
600 ppm. This concentration was determined by a trade-off wd th the volume
	
°^	
3
of the disinfectant reservoir needed versus the actual concentration of the
_Betadine applied within the fluid pathways. After mixing with the 18 ml of the
	
w	 20% urine/water residual, the final concentration of Betadine was then
	
.!	 calculated to be ti 536 ppm: I
150 ml' (Betadine Flush @ 600 ppm) 	
_ ti 536
150 + 18 ml residual	
x 600 -	 ppm
	
m ltYl	
Y
E	 Note - 50 ml Betadine from disinfectant reservoir (at concentration of 1800
ppm) was mixed with 100 ml water, recirculated through instrument,
	
'..	 and allowed to stand for 30 minutes.wow
i
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I Two disinfectant trials in the ABSS were carried out with these concentrations
of Betadine.
	 The experiments were conducted on two separate days following
I
daily addition of the marker (E. coli ),and at least 7 additional normal urine
inputs.	 The effluent urine sample immediately before and after the "Disinfect"
r
f cycle (which requires
	
. 1 hour,including the 1/2 hour dwell time) were
1-
titrated in both trypticase-soy and EMB agars,
	 Results of this data are
I
displayed in Table 3.2.4.4.2.2,
Betadine at the concentration indicated was ineffective in significantly u
f reducing the viable titers of the indwelling contaminants. 	 The small re-
ductions observed, approximately 1 log, are probably the result of a dilution
effect.
3.2.4.4.2.3	 Effect Of Betadine On Urine Waste Tank
In anattempt to control high levels of microbial contaminants within the
urine waste tank, Betadine was added to the reservoir each operational day
-before insertion of the first urine input (See Section 3.2.4.2-1).	 Samples
I
of the final urine/Betadine-mix were assayed for the microbial count at the
end of each operational day. 	 Results are exhibited in Table 3.2.4.4.2.3.'
As shown, microbial counts increased by 2 log increments each day from 104
to 108 organisms/ml.
	 The amount of Betadine added each morning was based
f on 'projected volume of urine inputs.
	 By day 3 concentration of the dis-
infectant was judged low, thus an additional 200 ml was added on day 3 in an x
effort to increase the average concentration.
	 However, as shown by the
IWO	 ,.
data, the higher level of Betadine was unable to affect the steady increase
in bacterial multiplication.
IN
It was obvious, therefore, that higher concentrations of Betadine were re-
1	 d J quired to achieve a stable population of ti 10 6
 organisms/ml.
t :^
t
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kTABLE 3.2.4.4.2.2
TRIAL	 CONDITION
EFFECT OF BETADINE DISINFECTANT
ON MARKER_ ORGANISMS (E. COLI) AND
RANDOM CONTAMINANTS WT'THITTLUID
PATHWAYS'OF ABSS (SAMPLE ALIQUOT)
URINE INPUT	 URINE SAMPLE COUNTS
	
I
EMB AGAT
NO. VOL PRE-COUNT TSA E. COLI OTHER TOTAL
1 Pre- 212 2 x 101 -2 x 104 8 x 104 5 x 105 5 x 105
Disinfection
Betadine
Disinfection* Approximately 1 Hour
@ 536 ppm
Post- 112 1	 x 10 3 2 x 104 1 X 10 3 1 X 104 1 X 104
Disinfection
2 Pre- 208 9 x 10 1 6 x 105 8 x 104 5 x 10 5 5 x 105
Disinfection
77 Betadine
_
fi`
i1Pi Disinfection Approximately 1 Hour
@ 5,26 f pm
Post- 201 <10° 2 x 106 6 x 104 5 x 106 5 x 106
Disinfection
,Ys
* Disinfection = Betadine at 600 ppm (1800 ppm in Reservoir) with 1/2 Hour'
Dwell Time
TSA = Trypticrase Soy-Agar
EM6 =Eosin-Methylene Blue Agar
E
j
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TABLE 3.2.4.4.2.3
EFFECT OF ADDITION OF BETADINE
TO URINE WASTE TANK OF ASSS
AT START OF EACH OPERATIONAL DAY
Urine Input Betadinel Urine Pool Coun t2
Day Total Daily No. Of Amount Ca c.	 I2
Vol.	 (ml) Inputs Added (ml) Conc.	 In
ppm (Final) 3 E..	 Coli Other
lc 3312 15 100 233 1 x 104 1 x 104
2 2287 14 100 345 7 x 104 2 x 106
3 2429 10 300 586 2 x 108 2 x 108
g
a
ihT
j:
3.2.4.4.3 In Vitro Assay Of Betadine In Water And Urine Versus E. Cold
An effort was made to better understand the potential efficacy of Betadine
as a possible agent for decontamination of the ABSS/WCS as well as for control
of microbial populations within the urine waste pool. A preliminary in vitro
assessment of bactericidal activity of Betadine in both water and fresh
urine was organized as follows: Duplicate dilutions of Betadine undiluted,
1:2, 1:10, 1:30, 1:100, and 1:1000 were made in water and urine so that the
total volume of each dilution was 100 ml. The concentrations of Betadine
were 10,000, 5,000, 1,000, 300, 100 and 10 ppm respectively; while the
corresponding concentrations of water/urine were 0, 50%, 90% 96.6%, 99%)
and 99.9% respectively. E. coli was added to each combination in an amount
calculated to produce ti 10 6 organisms/ml. After 30 minutes incubation at
room temperature, an aliquot was removed from each flask and placed in a
thiosulfate buffer (to neutralize any residual Betadine) at a 1:10 dilution.
Portions-of this dilution were added to trypticase-soy broth, incubated at
35°C, and observed daily for evidence of microbial growth.
1
Y
The data is displayed in Table 3.2.4.4:3. As shown, all concentrations of
Betadine tested were effective against the standard chall enge of E. coli
when the diluent was water. With urine, none of the concentrations were
effective. In may be speculated that the sharp differences demonstrated by
th;is preliminary test were due to the presence of protein in the urine which
was capable of complexing the freely disassociated iodine, and then driving
the povidone - iodine mixture to the extinction of all _iodine. This situation
has been demonstrated with quaterinary ammonium disinfectants and has been
cited as the reason for their relative ineffectiveness in the presence of
1
r	 organic material.
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Betadine
Conc.-
PPM
% Water-
Uri'ne
10,000 i	 5 11000 1,000 300 100 10
Water +
0
Urine N/A
Water +
50
Urine 0
Water
90
Urine 0
Water +
96
Urine 0
Water +
99
Urine 0
Water +
99.9
Urine 0
Y^
t	
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TABLE 3.2.4.4.3
RESULTS OF IN VITRO ASSAY OF DILUTIONS
OF BETADINEr Iff WAM AND URINE VERSUS
E. COLI AT A CONCENTRATION OF 106 ORGANISMS/ML
FOTLO^GITN-"O MINUTE INCUBATION AT ROOM TEMPERATURE
1 I I f ^^
3.2.4.4.4 Simulation Of WCS Operation With Betadine Disinfectant
Previous data has shown that normally occurring microbial contaminants in
urine will, if unattended, quickly multiply in the waste urine tank with
concomitant odor, gas pressure, and infection dangers to the crew. In
addition, any crack, crevice, or dead-end space within the fluid pathways
of the instrument is a_potential reservoir of microbial contaminants which
will continue to inoculate microorganisms into the waste tank. The Waste
n
Collection System (WCS) is a significantly less sophisticated instrument
with correspondingly shorter fluid pathways, and a simpler operational
sequence.
For these reasons, it was of value to modify the ABSS so that in operation
it simulated the WCS, and then assess the potential efficacyof Betadine in
p=	 this system as a disinfectant in order to achieve stability in the urine
i
r
waste pool. The following changes were made in the ABSS:
1. Lines from the accumulator were reconnected directly to the urine
waste tank. This automatically provided the following:
• Elimination of the entire programmed sequencing of the ABSS,
e.g. no recirculation, no air punge, etc.;
• Prevention of the operation of the accumulater urine
flowed directly through as though
_a part of the fluid lines;
• Significant reduction in the time requred to process any
urine input.
2. Rinse water cycle was eliminated. fi
3. Fi fteen ml of Betadine (10% Povi done-Iodine) was added to each
+	 urine input simultaneously with the addition to the instrument.
,r	 The 15 m1 amount was based on an expected average input volume of
.	 250 ml and an arbitrarily selected frequency of 8 inputs/operational
114	 day. Thi s would provide an average free iodine concentration of >
600 ppm_by the end of each day's intake.
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In an experiment designed to assess this modified WCS, aliquots were drawn
from the urine waste pool at the start of each day, after the median urine
(4th or 5th); and after the final one. Each aliquot was titrated immediately
in trypticase-soy agar. The urine waste reservoir was re-connected each
evening to a water manometer and allowed to stand at room temperature over-
night (See Section 3.2.4.2-3). Pre-test decontamination with 2% peracetic
acid reduced measurable bacterial counts within the modified ABSS to < 1
organism/ml. Table 3.2.4.4.4 records the results of this study.
As shown, total counts of the urine waste tank were low (10 2 ) through the
first day, and increased to 10 6
 by day 3 with no measurable pressure being
recorded. Visual observation of the tank showed that the urine/Betadine
mixture remained translucent throughout, although there was an increasing
accumulation of debris at the bottom of the reservoir.
	 By day 4 - after ^x
standing overnight, but with no new addition of urine - the count had risen
to 107 , still with no measurable pressure, positive or negative.
	 The average
a
Betadine concentration within the urine tank over the 4 day test period was
equivalent to 727 ppm free iodine.
These results suggest the following interpretations:
1.	 Levels of Betadine at average concentrations of 700 ppm free iodine w
are able to show bacterial activity to the extent that gas pro-
duction/consumption is significantly reduced over the time period
encompassed by the test.
2.	 Lack of production of any pressure and the maintenance of -trans-
lucence with the urine pool reservoir suggests that some level of
"stability" has been approached.
3.	 However, continued increase in the total count indicates that multi-
plication of the microbial	 population is not being held in check by
i	 the concentrations of Betadine present.
4.	 Therefore, higher concentrations of Betadine will be required to }
establish and maintain a "stabilized" urine tank.
	 In allprobability,
the increase in weight and volume of Betadine which is suggested
by these experiments would be unacceptable,
-ft" 	 Woo
TABLE 3.2.4.4.4
WCS SIMULATIONI: ADDITION OF 15 ML BETADINE2 /URINE INPUT_;_
NO SAMPLE MODE; NO WATER RINSE EFFECT ON URINE TANK
I.
Urine Cumulative Fluid Totals Urine Tank
Total Daily Tank Urine Urine Free I2 vermg t
Day Urine Vol/ Sample Betadine Conc. -% Conc.-ppm Count/ml3 Gas Production
Input No. Sequence Vol.-ml
1 1499/8 First 181 91.7 827 2 x 102
Middle 1160 93.5 647 4 x 102 ND
Last 1619 92.6 741 3,x 102
2 1484/8- first 1618 92.6' 741 5 x 102 < 1 mm
Middle 2731 92.8 714 3 x 105-
Last 3223 92.5 745 4 x 105
3 1770/8 First 3223 92.5 745 4 x 106 < 1 mm
Middle 4507 93.0 699 4 x 106
Last 5113 92.9 704 4 x 106
4 First 5113 92.9 704 5 x 107 < 1 mm
1. Following-changes-were made on ABSS to provide the WCS Simulation: 1) Discharge lines 	 r
from accumulator connected directly to urine waste tank; 2) Water rinse disconnected.
2. Betadine full strength (10,000 ppm) was added to each urine before circulation through
4!CS; total daily amount of Betadine added = 120 ml (8 x 15).
3. Bacteria plate count for first sample on Day 2, 3 and 4 represents overnight incubation
at ambient temperature.
3.2.5	 Miscellaneous Information - ABSS Testing
During operation of the ABSS and throughout the various tests/studies,
relevant information, facts, operational detail, etc. have been accumulated
which do not bear directly on any of the specific problems being addressed.
Listed below is a compilation of this information which can be useful in the
total evaluation of the ABSS and for use in future design/experiments.
Total Fluid Input 102 liters
No. of Inputs 341
a	 Total Urine Input 28.3 liters
I	
;
No. of Inputs 143
Ave. 198 ml
Male Urine
No. 92
Ave. 209 ml
Geom. MLan 202 ml
'"
Total 19.2 liters
Female Urine WOOF
No. 51
Ave. 178 ml"
Geom. Mean 174 ml
Total 9.1	 liters
«Y
a	 Operational	 Information
Recirculate Cycle 45 Sec.'s
Sample Cycle 0.47 Sec./ml
Air and Water Purge 190 Sec. a
_	 r
Total Operation Time 34.2 hours
e	 Naturally Occurring Microbial Titers g
Male 6 x 102 org./ml
Female 2 x 103 org./ml ^.
Note:	 Pre-use counts were accomplished by incubating replicate
plates containing 1 ml of urine in trypticase-soy agar.
Urine counts on female sample were often overgrown and the
titers were arbitrarily set at 10 3 . Therefore, average count
of female urines is probably slightly higher.
-50-
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3.2.4.5 Conclusions And Recommendations
3.2.4.5.1 Conclusions
Results of the studies presented in this Section which involve the response of
the ABSS to urine microbial contaminants and Betadine disinfection have
demonstrated the foll owi ng:
Microbiological Responses
• Fluid pathways within the ABSS contain a number of reservoirs (dead-
ends, cracks, etc.) which quickly capture and hold available micro-
biological organisms within the ABSS.
e These pockets, or microbial reservoirs, re-infect (cross-contaminate)
all incoming fluids.
t Frequent rinsing with normal urine inputs did not reduce the high
titers (ti 107 ) maintained within these pockets.
e The waste urine tank at ambient temperatures, provides excellent
media for rapid multiplication of microbial organisms with concomitant
production of:
High titers of microorganisms (ti 108)
Gas pressure - positive or negative	 -
• Peracetic acid (2%) was notable to flush pockets of contamination
within the fluid pathways of the ABSS.
Betadine Disinfection Studies
Betadine at concentrations of up to 578 ppm of free I2 was ineffective
in either reducing or controlling populations of the E. coli marker,
or the naturally occurring urine contaminants within the f uid pathways
of the ABSS.
• Betadine at concentrations averaging 727 ppm of free I 2 appeared to
inhibit the formation of gas pressure (positive or negative) in the
waste urine tank of the VCS simulation.
Therefore, the following conclusions are suggested:
1. The ABSS, in its current design, is inappropriate as an instrument
to provide representative urine samples for research-level testing,
j
t
k
1
due to the inherent susepti bi l i ty of the fluid pathways to form
pocketsof contamination and then re-infect (cross-contaminate)
succeeding urine inputs/samples.
2.	 Betadine is generally unacceptable as a disinfectant and decontaminant
f	 for the ABSS, due probably to presence of quantities of organic
f	 material	 (primarily protein) which inactivates the available iodine
as fast as it is released.
F;
3.	 Stabilization, or maintenance of the microbial population below
pre-set limits, e.g. ti 10 6 organisms/ml, is probably an unrealistic
goal, especially with Betadine. 	 Objective should be for total in-
}	 activation of all microbial activity as a-solution for the control
of biological events within the fluid pathways and waste urine
reservoir.
4.	 Modification of ABSS to simulate the WCS activity provided, from
the microbiological response viewpoint, a very positive improvement:
F	 Significantly newer pockets of contamination, faster processing, and
inhibition of gas pressure.
3.2.4.5.2	 Recommendationsa
Experience with the ABSS and Betadine as the disinfectant underlined the
factors, mentioned earlier, which influence the microbial activity within a
K'f
urine collection system, i.e. type and mix of microbial organisms, population
size, antimicrobial spectrum of the disinfectant, and volume/frequency of
^x
urine inputs.	 The permutations among these variables and others would
involve an unacceptably high volume of testing.	 An effective solution to
this dilemma is to provide an overkill with the disinfectant employed, i .e.
A
j	 .
^x
efficacious, broad spectrum ,of antimicrobial activity. 	 Therefore, the fol- ,±
recommendations suggest themselves:
•	 Compile and investigate new candidates for use as decontaminants
in a Waste Collection System (urine, feces, condensate, wash fluids,-
etc.) with a combination of the following: y,.
Both chemical and antibiotic agents, e.g. streptomycin,
neomycin, etc.. as .potential .disinfectants; $: 	 `
x
r
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- 	 Use of two or more agents in comLination;
-	 Possibility of incorporation of the agent(s) into dry (freeze.-
dried ?) or pelletized form which will;
t
Reduce
	 toxicitya.	 or eliminate potential
b.	 Decrease volume requirements
c.	 Reduce weight demands.
•	 Redesign of fluid pathways so as to accomplish:
E
-	 Elimination of cracks, crevices, dead-ends within internal
structure of fluid pathways.
-	 Severe reduction in length of flu"A pathway.
S^
9
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4.1 Test Plans And Protocols
4.1.1 ABSS Micro/Biochemical Assay
Purpose
	
To provide a "first-cut study" on the microbiological and bio-
Ji
chemical response of the ABSS within the following parameters:
• Short-term and long-term effect of known bacterial
contaminants within the instrument;
• Efficacy of Betadine as an antibacterial flush;
• Ability of the Microbiological Sampler to provide
effica;ious, real-time samples for microbiological
sampling; and
• Continuing assessment of the potential effects of chemical
cross-contamination on the ABSS.
Discussion The complex chemical and microbiological inter-relationships within 	 }
a sophisticated instrument such as the ABSS cannot be completely:
explored or defined with one experiment. It is planned that this
experiment, therefore, will involve the basic elements of those
i
parameters, and will serve as a foundation for additional
experiments to provide more explicit definition.
Method	 A. Microbiological Elements
1. Short-term /long-term effect of known contaminants
• Test organism - E.coli, ATCC #15144,
..	 • Carrier - Urine, obtained as fresh, random volumes from
Males only.
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•.	 Level of infection - approximately 10 6 organisms/ml
•	 Baseline Conditions
-	 ABSS will be dried-out as per chem. cross-contam. ^.
studies, and fresh male urine added to instrument to "load"
the ABSS with urine, as under normal user conditions.
-	 Pre-test aliquots will be taken from every urine input
for assay-Biochem ./Micro.
-	 Effluent from Sample and Dump ports will be collectedx
separately from each urine input.	 Collection will
be made in pre-weighed, sterile containers.
-	 All! urine inputs will be weighed before addition
to ABSS.
-	 ABSS will be assayed before start of experiment for
background microbiological load.
•	 Schedule of urine sample inputs - These inputs will bek,
using the fresh, male urine collected on random basis.
-"Seeded" sample - 0 time
x.
-	 1st sample - 5-10 minutes post
-	 2nd sample - 1 hour post
-	 3rd sample - 24 hour post
-	 4th sample - 48 hour post
-	 5th sample - 72 hour post*
•	 Assays - All pre and post samples will be titered in
Trypticase-Soy 'Broth and Agar according to a dilution
r ^i ^
schedule in a following section.
-5b-
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2) Efficacy of Betadine as an anti-bacterial flush.
s Organism - E.coli ATCC #15144 (As Above).
! Carrier - Urine freshly collected, male, random volume
(As Collected).
• Betadine concentration - 10% in water solution furnished
in commercial containers.
•	 Am giant - As prescribed by automatic "Disinfect" cycle
together with rinse water.
•	 Sample schedule
-	 Seeded Urine - 10 6
 organisms/ml
-	 Betadine Flush - 5-10 minutesP ost
-	 lst Sample - 1 hour post
-	 2nd Sample - 24 hour post
3)	 Efficacy of Microbiological Sampler - See separate protocol
for Micro Sampler.	 Assay is carried on away from ABSS 	 since
the instrument itself is not critical to the abili ty to
^	
1
" provide real-time sample for microbiological assay.'
B.	 Biochemical Elements
1.	 Biochemical Parameters
•	 Phosphates - As inorganic phosphorus -See separate
protocol for details of assay. 	 (^o'lorimetric Assay).
•	 Specific Ion Analysis - Electrochemical
Chloride (cl-)
t Sodium (Na )
-	 Potassium W)
-	 Calcium (Ca++)
-57'-
yI'	 • Dip Stick Analysis (Ames) - Color Comparison
	 w
- pH
- Glucose
<<	
- Protein
- Acetone,
- Occult Blood's
-k
I	 - Bilirubin
- Urobilinogen
Occult blood test, from list above, is extremely sensitive
to hemaglobin (Hgb). Therefore, a stock solution of Hgb
will be obtained by mixing fresh, whole blood with
distilled H2O. This stock will be titered (See Separates
Protocol) for limit of sensitivity to the "occult blood
pad" on the dip stick by dilution in water.	 ^`*
2. Sample Schedule - Biochemical tests as listed above will be
performed on each urine sample as defined under the Microbio-
logical Elements section.
• Pre-add'n aliquot - 20 ml.
!	 • Post-add `n -from Sample/Dump lines - as collected.
i	
• All urine will be weighed (After Removal of
Pre-add 'n aliquot)_.
• All samples ( Sample/Dump) will be weighed and
recorded for calculation of urine recovered versus
urine added.
5
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3. Assay
•	 Phosphate
.
- As soon as possible after obtaining each
sample, a 1:100 dilution in H2O will 	 be made and stored
°C	 Assay	 beat , 4until assay can be performed.	 will
f
done so as to provide complete data (1 pre and 2 post)
on each sample simultaneously.
Materials	 1. TS Agar - 5 liters, in 500 ml 	 lots.
tv"t 2. Petri Plates	 - ti 180 = 9 packages.
1 3, Sterile flasks for primary collection of urine
12 500 ml	 flasks.
4. Sterile flasks for collection of samples.
•	 Sample Port - 15 250 ml flasks °.
•	 Dump Port	 - 15 500 mlflasks
5. Sterile 2-hole stopper assemblies - All 	 stoppers will contain
opening for tubing from Sample port and cotton stuffed _air-
:r relief tube wrapped individually in brown paper and sterilized
in the autoclave.
-.1
r •	 Sample Port - 15 2-hole #6-1/2 stoppers
•	 Dump Port	 - 15 2-hole #8 stoppers
6. Sterile in-line air filter for nitrogen line.	 -
7. Sterile	 individuall	 wrapped rubber tubing with	 Lass deliverY	 pp	 9	 9	 Y
It tu be for insertion into Sample port at each urine addition.
15 units
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8. Sterile pipettes, 10, 5, 2 ml - as needed.
9. Sterile H2O - in 900 ml lots - 6 - 8.
i!
r
S4	 ^	
7
eRyt
1ff^I
ki
i	 Timeline/Procedure
Monday - 24 March
1. Wash several lots of sterile water through ABSS. Capture final
50 - 100 ml portion with sterile assembly and assay for microbial
background.
°	 2. Drain fluid and dry-out fluid pathways of instrument.
3. Refill instrument with pre-weighed urine. Pre-sample urine before
.
	
	
putting into instrument. Sample and titrate aliquots from Sample
and Dump ports of instrument. (3 titrations/sample to values of
 0.1 ml, 1 ml, 10 ml)
4. Introduce 2nd urine sample into instrument after having added
hemoglobin reagent.	 Pre-sample urine before putting into instrument.
! Sample and titrate (3 per sample to values of 0.1 ml, 1 ml, 10 ml).
f 5. Inoculate two (2) 500 ml flasks containing 50 ml TSB with E. coli.
fr Tuesday - 25 March
1. Take pre-sample of first urine. 	 Inoculate remaining urine with €,
E. coli to approximately 10 6 organisms/ml.
Titer E.	 coli	 inoculum,	 106 ,	 107 ,	 108
'urine,Titer seeddetc	 10 5 , 10 6 , 107
2. Add seeded urine to ABSS. 	 Take sample aliquots from Sample and
Dump ports and titer 10 5 , 10 6 , 107.
_ 3. Pre-sample urine (unseeded); titer 0.1, 10,`1 ml.	 Take 'sample
aliquots from Sample and Dump ports and titer 10 1 , 102 , 103, 104 . k
4. Add unseeded urine sample (urine sample #5).
	 Pre-sample urine before
addition to ABSS and titrate to 0.1, 1, 10 ml.	 Take aliquot samples
from Sample and Dump ports and titrate to 10 1 , 102 , 10 3 .	 (Two
plates each)
' Wednesday - 26 March
1. Add 6th urine sample, unseeded, to ABSS after first taking pre-sample
aliquots at values of 0.1, 1, 10 ml. 	 Take aliquot samples from
Sample and Dump ports at values of 0.1, 1
	
10 ml.	 (Two plates each)
Ci k.l	 i
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Thursday - 27 March
1. Add 7th urine sample, unseeded, to ABSS. Pre-sample urine before
addition to ABSS and titrate to 0.1, 1, 10 ml. Take aliquot samples
from Sample and Dump ports at values of 0.1, 1, 10 ml (Two plates
each).
2. Inoculate two (2) 50 ml flasks with E. coli and incubate at 37°C.
Friday - 28 March
1. Add 8th urine sample (unseeded) to ABSS. Pre-sample before addition
taking 0.1, 1, 10 ml samples. Collect aliquots from Sample and
Dump ports. Titrate at values of 0.1, 1, 10 ml (Two plates each).
Pre-sample 9th urine sample taking 0.1, 1, 10 ml samples.
Into the remaining urine inoculate E. coli to obtain a concentration.
of 106 organisms per ml using freshcu ure from 27 March. Sample
and titrate to values of 10 5 , 106 , 107.
Add seeded urine to machine, process, and collect aliquots from
Sample and Dump ports. Titrate to values of 10 3 , 104 , 105 (Two
plates each).
Activate "disinfect" cycle on ABSS.
Add 10th urine sample after taking pre-sample aliquots of 0.1, 1,
10 ml. Sample Dump and Sample ports and titrate to 0.1, 1, 10 ml
(Two plates each).
Perform add-backs to confirm ability of media to support growth
using spore strips.
Pre-sample 11th urine at aliquots of 0.1, 1, 10 ml. Add sample to
ABSS and Sample Dump and Sample ports and titrate to 0.1, 1, 10 ml
(Two plates each).
2.
3.
4.
5.
i
i
i
a
..	 1
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4.1.2 Betadine Rinse - WCS Study
Purpose
To investigate the effect of use-by-use application of Betadine to a urine
collection system which operates in the absence of a water flush and without proportional
sampling requirements.
Discussion
The WCS, as currently designed, will receive urine, remove the gases, and deposit
the liquid in a closed, variable volume storage container.
	 At some point within the
WCS a defined volume of Betadine will be injected into the system during-each use.
The.total daily, amount of Betadine will be enough to provide a minimum effective-con-
r centration	 Of 1 2 forthe maximum expected volume.	 It is necessary to determine
whether Betadine equivalent to 600 ppm free 12 in the waste container is effective
in preventing the growth of microorganisms.
One of the problems associated with such growth is the possibility of increased
or decreased pressure within the waste container due to production or assimilation of
gases.
Procedure P
In order to simulate conditions in the WCS, the lines from the accumulator in
the ABSS will be disconnected and made long enough to reach a waste container. 	 The
ABSS will be treated twice, for 15 minutes each time, with 500 ml 2% peractic acid
containing 0.05%
	 Nacconol 60TL.	 Sterile water rinses of about 500 ml will be put
through the unit until the pH of the effluent is approximately equal , to that of
U
sterile water.	 A titration of the organisms present will be made on the final rinse
effluent.
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For three days eight urines/day will be circulated through the altered unit into
a sterile six liter Florence flask fitted for attachment to a manometer. One
urine/day will contain E.coli at 106 organisms/ml. Before introduction, 15 ml of
commercial (10%) Betadine will be injected into the sample. This amount is sufficient
to give 600 ppm free I 2 in the waste container if the average input is 250 ml. No
water flush will be used and ABSS will be turned off between samples.
An aliquot of the waste fluid will be treated with sodium thiosulfate to neutralize
the 12 and titrated on trypticase soy agar and on EMB agar after the first, fifth and
last samples on the first day and initially, and after the fifth and eighth samples
on the second and third day..
A manometer will be attached to the waste container at the end of each day to
measure changes in pressure'overnight.
1	 1
F
E
Operational Procedure:
1. Weigh urine, add E coli 1/100 if called for, and introduce.
2. Titrate E.coli at 10"7 , 10-$
3. Take aliquots of waste after first (or before first on days 2 and 3)
v^
sample,and fifth and eighth samples.
4. Dilute aliquots	 1/10 in neutralizer-phosphate buffer prepared by taking
11 ml of sodium thiosulfate, 4%,in 99 ml phosphate buffer.
j5. Dilute 1/100 1/10 1/100 in phosphate.
} 6. Plate 0.1 ml on EMB x2 and on trypticase soy x 2.
y	 7. Attach manometer at the end of the day and record pressure the next
morning.
l ''
4.1.3 ABSS/Betadine Rinse Study - Part I
Purpose
	 To determine the level of available iodine 02, in PPM) necessary
to neutralize or decontaminate the expected water/urine/bacteria
mixture present within the ABSS following a normal usage day.
Discussion The normal water rinse of ti 70 ml, following the input of urine
to the ABSS, will dilute the residual urine (from the input) to
about 20%, i.e. 18 ml residual urine + 70 ml rinse = ti 20% urine.
When the Betadine/water disinfect rinse is employed, the 20%
urine residual is the fluid within the instrument which will be
`encountered. Therefore, it is necessary, as a first step, to
determine in vitro what levels of I 2 will be effectiveagainst
various mixtures of contaminated urine/water.
Procedure	 The study will employ a matrix of 4 x 4, i.e. 4 levels of Betadine
Theory
encompassing the concentrations which are expected to be employed
versus 4 mixtures of urine/water/bacteria also encompassing the
range of dilutions expected. Graphically, this is represented
by the block below;
I
^'	 I	 I	 l	 I	 1	 i	 I
The "Disinfect" cycle is normally employed as follows: 50 ml is
pumped from the disinfectant reservoir followed by 100 ml of
sterile rinse water. This 150 ml mixture becomes a 1:3 dilution
of the Betadine from the reservoir. When the 150 ml is circulated
throughout the fluid pathways, it then mixes with 18 ml residual
mixture of water/urine. This ratio of 
168 
is equivalent to 10
11.2
Therefore, 1.2 ml of each water/urine/bacteria (contaminant)
mixture will be placed in each row of -4 tubes. The 4 dilutions
of Betadine containing 100, 300,600 , and 1000 PPM, respectively,
Wi ll be added at the level of 10 ml to each rank of 4 tubes so
that each dilution of Betadine will be ex posed to each concentra-
tion of water/urine/bacteria in the approximate dilution ratio
expected within the ABSS.
The dwell-time of these mixtures will be 30 minutes (dwell-time
of disinfectant rinse in the ABSS) followed by 1:10 dilutions in
sterile sodium thiosulfate, to neutralize any residual
	
I2, and
i=< two additional
	
1:10 dilutions in sterile phosphate buffer. 	 Each
of these dilutions will be plated using EMB Agar, incubated at
35°C for 24 hours, and enumerated to determine the titer of each
experimental mixture.	 -
Procedure	 1)	 Set up the sterile 16-tube matrix with appropriate labels.
Opera-
tional	 2)	 Prepare the urine/water mixtures in separate tubes as follows:
0% urine - 19.8 ml	 sterile H2O
10% urine - 2 ml urine + 17.8 m1 sterile H2O
020% urine - 4 ml urine + 15.8 ml sterile H 2
30% urine - 6 ml urine + 13.8 ml sterile H2O.
:^.
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3) To produce the bacterial contaminant for each mixture, add
0.2 ml of an 18 hour culture of E.coli
	
(ATCC 15144) to each
tube for a 1:100 dilution of the bacteria.	 This should
provide a final concentration of ti 10 6 organisms/ml for each
water/urine mixture. ;.
4) Betadine dilutions - Since the Betadine solution will be
further diluted in the ABSS by the introduction of the rinse
water (100 ml) for an additional 1:3, the initial dilutions
will be as follows:
V
Final. Betadine
	 Final	 Dilution	 Stock	 Sterile
Conc. Desired-PPM
	 Required	 Betadine	 Water
100	 1:100
	 0.5 m1	 +	 49.5
^.
300	 1:33	 1.5	 +	 48.5 1
600	 1:15	 3.3	 +	 46.7 G
1000	 1:10
	
5.0	 +	 45.0 T
5) Make 20, 9 ml blanks of Na Thiosulfate/Phosphate buffer (See
Materials For Formula).
6) Make 35, 9 m blanks of phosphate buffer (See Materials).
7) Add 1.2 ml of the appropriate water/urine/bacteria mixture
to each row of the 16 tube matrix.
8) Add 10 ml of each Betadine dilution to the appropriate rank
of water/urine/bacteria mixture at 10 second intervals so
that the dwell-time for each of the 16 experimental mixtures
can be controlled to exactly 30 minutes.
Ir
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9) Remove 1 ml from each tube in the same order it was added
at 10 second intervals and place in the 9 ml blank of
neutralizer/buffer - mix thoroughly.
10) Make 2 more successive 1:10 dilutions from each tube and
j	 plate 0.1 ml on 2 replicate EMB plates/dilution for a final
F
	
titration of 102 , 103 , 10 11 . Incubate at 35°C for 24 hours.
I'
	 Materials
	
1) 20 mm screw-cap tubes for matrix - sterile, 18 needed.
2) 9 ml neutralizer/buffer blanks - sterile, 18 needed.
3) 9 ml buffer blanks. sterile, 35 needed,
e
4) Neutralizer - See previous protocol.
^. 5 Buffer - Seerevious protocol.P	 P
q; 6) E.coli - Inoculate 18 'hours pre with 1 drop from previous
Y culture.	 Incubate at 35°C.	
;!
7) EMB plates - 100 needed.
8) Spreaders - Approximately 35 needed, sterile.
9) Betadine - Stank.	 t
I
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4.1.4 Betadine/ABSS Rinse Study - Part II
Purpose
To examine the effect of daily Betadine rinses in the ABSS using levels of
Betadine that have been determined in vitro to be effective against the expected
water/urine/bacteria concentrations.
E	 Discussioni
Programmed operation of the ABSS following input of urine calls for the
elusion of-70 ml of rinse water after passage of the urine. The expected 18
ml residual of the urine within the system when mixed to this 70 ml water results
in approximately a 20% urine mixture as the new 18 ml residual. Previous in vitro
testing has established that 600 ppm of Betadine will effectively inactivate
(neutralize) the contaminant in this 20% urine/water mixture. Therefore, the
thrust of this experiment will be to use this Betadi-ne concentration within the
"Disinfect" cycle of the ABSS and determine if any significant effect of the
Betadine so added can be discorned under actual "use" conditions
Baseline Conditions
1. Test will be conducted for two use-days using the programmed single
"Disinfect" cycle per day. ;.
2. ABSS will be decontaminated/cleaned in 2% _peracetic acid before start
oftest.
3. Minimum number of urine inputs will be 1Q/,¢ay.
^.	 4. One "loaded" urine sample, 	 i.e. E. Coli at 106 /ml, will be added to the ^...
instrument at the start of each test^ay.
r	 5. Selected samples of the effluent "Samples" port will be taken each day and
titrated for total count of bacteria.
6. Titrations will, be conducted on aliquot samples of the urine pool.'
u
7. All samples except the pre-urine sample, will be titrated in both EMB and
TSB.
P
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iTimeline/procedure
Monday - 30 June
1. Place urine pool reservoir (19L jug) 	 in position for use - all connections.
2. Run final sterile water rinse through, collect sample, and ti-rate in
TSB for possible level of contaminants in system at start - use spore
strip in tube as control for residual peracetic acid.
Dilns - 10 2 -3 ^`+ (2 replicates/diln.)
° 3. Inoculate flask of TSB broth w drop from previous culture - 4 p.m.	 - to
	
Mj
give 18 hour growth at 35-C (E. col,i).
4. Prepare Betadine solution and add to reservoir bag.
Tuesday, 1 July  '
0 min	 1 ml Pre-sample - Urine 1 1-1
^. Add E, coli	 (1/100 diln) and titrate 1-2µ
4,5,6 Sample - Urine 1 -3^
30 min.	 1 ml Pre-sample Urine 2 1-4
3,4,5 Sample Urine 2 1-5
1-4 hrs..	 1 ml
	
Pre-sample, Urine 3,4,5 1-6
	 1'!
1-7
1-8
4 hrs.	 1 ml Pre-sample - Urine 6 1-9
2,3,4 Sample Urine 6 1-10
5-7 hrs.	 1 ml Pre-sample Urine 7, 8 1-11
1-12 i
7 hrs.	 1 ml	 Pre-sample Urine 9 1-13
2,3,4 sample Urine 9 1-14
7:15 Disinfect cycle using Betadine at final
..x diln. of 600 ppm.
8 hrs.	 1 ml Pre-sample Urine 10 1-15
2 ,3,4 Sample Urine 1-16
X`. 8:15 Aliquot of Urine Pool 3,4,5,6 1-17
Inoc. E. Coln flask
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Wednesday, 2 July
0	 min. 4,5,6 Sample Urine Pool 	 2-18
0 - 15 min. l ml Pre-sample 	 Urine 11	 2-19
2,3,4 Sample Urine 11	 2-20
1 ml Pre-sample - Urine 12	 2-21
4,5,6 add E. Cold, enter,'Sample 	 2-22
1 hour	 Pre-sample - Urine 13	 2-23
3,4,5 Sample --Urine 13	 2-24'
1-4 hours
Pre-sample Urine 14	 2-25
15	 2-26
16	 2-27
17	 2-28
^^	
1
i
3
5-6 hours	 Pre-sample Urine 18
	
2-29
	
6:15	 Pre-sample Urine 19	 2-30
2,3,4 Sample - Urine 19	 2-31
	6:30	 Disinfect Cycle
	
7:30	 Pre-sample Urine 20 	 2-32
2,3,4 Sample Urine 20	 2-33
	
7:45
	
3,4,5,6 Sample Urine Pool	 2-34
Thursday 3 July
0 min.	 4,5,6 Sample Urine Pool	 3-35
Disinfect with Peracetic Acid Soln. with usual sterile
H2O rinses and pH checks.
Materials i
1	 Sample Flasks ­ 250 ml with stoppers /air valve-sterile - need 17,
2. EMB Plates
	
	
Approx. 50 dilns x 2 plates /diln	 100 plates x . 20	 r
ml/plate ; 5 flasks or 2,5 liters EMB Agar.
3. TSB Agar	 - Approx. 70 dilns,x 2 plates/diln - 140 plates x• 20
ml/plate = 7 flasks or 3.5 liters TSB Agar:.
F	 4. 9 ml water diln. Blank	 - Sterile - 90 needed.
5. 99 ml water diln,Blanks - sterile - 20 needed,
6. Betadine diln,- TBD
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4.1.5 Hemaglobin Titration
Purpose	 To provide a stock solution of free hemaglobin of a known titer
with respect to the chemically sensitive pad for occult blood on
the Ames Multistix tabs for urine assessment.
	
..	 Discussion- Investigation of the potential chemical cross-contamination of
	
wig	 individual urine inputs to the ABSS requires in part, an easily
detectable biochemical constituent in the urine which will act asf;
^M
a tag or tracer. High sensitivity of the Ames Multistix to Hgb. make
thi s an ideal system for that purpose.
Method	 Freshly drawn, non-heparanized blood will be mixed immediately with
^a
sterile, distilled H2O to produce hemolysis. This solution of
hemolysin/hemaglobin will be considered the stock solution. Dilutions
	
^F	 will be made, first in water, then in urine, and tested for a positive
reaction to the occult blood pad on the Ames Multistix. Results of
	
-.	 Vnis titration will be used as the basis for addition to fresh urine
Y
x
samples during the test period of the ABSS.
	
U_	 Materials	 Sterile 5 
ml syringe.
.4	 Sterile dist. H90	 1 "liter.
I'
?k
Procedure	 1. Draw 3-4 ml	 venous blood and add immediately to equivalent amountY
of sterile H20-
2. Centrifuge, if necessary, to remove any debris or cell wall_
remnants from RBC.
	
Store supermatent at 5°C when not in use. ^rz
3. Make following dilutions of Hgb. stock in H2O:
i
10-1 to 10- 9 in 10 fold dilutions.
i
4. Test each dilution by adding 1 drop of H9  solution to appro-
priate test pad on Multistix to determine titer. -,
5. Repeat test at dilutions of smaller increments on either side
of the titer from 4 above.
6.
I i
Repeat on appropriate dilutions of fresh urine.
E
i
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4.1.6 ABSS - Microbiological Assessment And Extended Biochemical Cross-
Contamination Study
Purpose	 To ,make a preliminary investigation of the microbiological responses
for the_ABSS in its present configuration, and to extend the scope
of the chemical/bioc.hemical cross-contamination studies.
l
Objectives	 The specific investigative objectives may be subdivided as follows:
A. Biochemical Pa rameters to be studied
1. Phosphates as inorganic phosphorus - colorimetric analysis.
2. Specific ion analysis - electro chemical
	
-*	 -3Chloride (Cl - )
	
rj 7
	- Sodium (Na)
	
^;..	 Potassium (K+)
Calcium (Ca++
3. Dip Stick Analysis - Chemical comparisons
d
pH
a	
Glucose
k
	
.:	
Protein
Acetone
t
Occult blood (independent variable)
- Bilirubin
- Urobilinogen
.n
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B. Microbiological Parameters to be studiedr
1.	 Efficacy of the microbiological sampler. r
2.	 Effect of microbiologically contaminated sample,
-	 Persistance/contamination.potential following
urine inputs.
-	 Potential of fluid pathway within ABSS for impinging/
incubating bacteria from contaminated sample.
K
e
3.	 Efficacy of Betadine decontamination system.
Discussion	 All investigative areas must be studied as a scheduled unit follow-
ing establishment of all analysis techniques before start of primary '`^
experiment.
A. Baseline Conditions
1.	 All measurements conducted using freshly collected male
urine acquired on a random basis with respect to volume -*
and time.
2.	 ABSS will be 'loaded (full) with urine before experiment begins.
3.	 Analyses will be done onpre/post samples for all investigative
parameters.
4.	 Sample and dump port effluents will be collected separately
for each urine output.
5.	 All urine inputs will be weighed pre and post (sample-post
collection and dump post collection).
6.	 Free hemaglobin will be added to selected urine samples to
check detection sensitivity of Ames Dip-Stix:
,i
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iB. Pre-Test Analysis Experiments to be Developed
1.. Standardization and check-out of Orion Specific Ion Analyzer.
2. Titrati-on of hemaglobin in fresh urine vs. dip-stix.
3. Check-out of Micro-Sampler
- Establish constant amount of absorbant cotton/gauze to
be added to each Sampler wick.
Determine average amount of fluid absorbed by standardized
wick.
- Study sterilization of Samplers with dry heat (about 125°C
for 16-24 hours).
Titrate limit of sensitivity of wick with known dilution
of test organism.
4. Titration of test ohganism
Growth on nutrient agar
4.1.7 Microbiological Sampler — Preliminary Studies
Purpose	 To acquire baseline information on the Micro Sampler such as
( 1) standard amount of cotton/gauze needed in wick, ( 2) average
amount of fluid captured by wick, (3) sterilization procedures for
sampler system, and (4) establish "in vitro efficacy of sampler
with dilutions of test organism.
Discussion	 Information acquired in these preliminary tests will be required
for determination of schedule and assay requirements for in-use
test of ABSS.
Re
' Materials 	 1. Absorbant cotton!
2. Gauze.
x
3. Sterile 250 ml flasks containing Nutrient Broth.
4.. Stock col ution of E.coli containing about 10 8 org/ml.
5. Sterile tubes containing 9 ml H2O for di 1 uti-on . ti
r b. bottles containing 99 ml H2O for diluti -on.
7. Sterile 500 ml flasks containing 250 ml of Nutrient Broth.
8. Sterile Petri dishes and 1 ml pipettes. 	 - -,
E 9. Commercial	 spore strips for sterilization control.
10. Betadine disinfectant,
x
11. Sterile 1-litre flasks containing about 800 ml. distilled H2O.f
12. Sterile tongs.f^
i
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Procedure	 A. Standard amount of cotton/gauze for wick
1. Pack several SS wicks with cotton and others with gauze
to a nominal amount.
2. Weigh each wick so packed before and after to determine
amount of cotton used.
3. Do same for wicks stuffed with gauze.
B. Average amount of fluid captured by wick
1. Make several wicks with both cotton and gauze and pour
100 ml quantities distilled H 2O over wick while in assembly
inserted into urine cap.
2. Weigh wick, pre and post, to determine amount of water
absorbed by wick.
3. Choose either cotton or_gauze for ,se in wick on basis of
performance with these tests.
C. Sterilization Procedures
1. Pack all 6 wicks with material chosen in tests above
together with a spore strip.
2. Thoroughly clean aluminum containers for wicks u.d insert all f
7 7	 samplers and test spore strips within each container.
3. Place 4 containers within dry heat oven and set for 125 0C.
{	 Allow to remain at that temp, for 24 hours
4. Remove from oven, cool, and aseptically transfer SS wick_
from each container to a sterile flask containing Nutrient Broth.
T7
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5. Tn^ubate at ,5°C and check for growth daily and record
;r
for 2 weeks.
f	 j
6. To all flasks which exhi .bited negative growth, add back
	
Y t
fresh spore strip and reincubate at 35°C for 2 additional
	 w..F
weeks - monitor and record.
D.	 fficacy of Sampler "In Vitro"
1. All Sampler wicks are packed with standard amounts of
absorbant material, assembled, and sterilized with dry heat
as above.
2. Make aqueous dilutions in 100 ml quantities of a stock E. cold
culture containing about 108 org./ml as follows:
103 org./ml; 102
 org./ml; 10+4 org./ml;
and two (2) 100 ml. bottles of 10 0 org./ml.
3. Pr-pare large tube (sufficient size to easily hold urine
ra;, ptacle from ABSS) and partially fill with 20% Betadine
solution.	 k
4. Immerse urine collector in Betadine solution and allow to 	 M,
remain for 5 minutes.
5 Retrieve collector with sterile tongs and rinse thoroughly
r
with one bottle (800 ml) of sterile water. Collect final
s
20-30 ml. of rinse in sterile flasks and test entire amount
for presence of variable contaminants in NB. Check for 1 week r.
r, 
and add back 1 drop of 10$ org./ml E. coli for those flasks-
 
	 4
which do not demonstrate obvious growth of microorganisms.
ez
^tr
r
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6. Insert sterile Micro Sampler in urine collector as
Y
prescribed by design and pour each 100 ml dilution of
j
E. coli	 into the cup and allow fluid to drain over the
same- Pr in simulation of urine.
7. Remove Micro Sampler from cup and aseptically drop the wick
into the N.B.	 Immerse collector in Betadine solution and
treat as #5 above.
8. Continue through each dilution using duplicate testing at
the 10° dilution. 	 Micro Sampler #6 is used as control-at
conclusion of E. coli dilution wash collector and pour 100 m1 a
sterile H2O over control and treat as experimental samples.
9. Incubate all samples at 35°C - check daily for 1 week - add
back E.	 coli	 to all	 negative samples.
10. Record all results.
1
1
»
s
y
^ r
i
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4.1.8 7-Day ABSS Operational Trial
GENERAL OBJECTIVE:
The overall objective shall be to complete a restricted but overall seven-day 	 y
test of the ABSS with frequent urine inputs, under a nominal••"Operation"
schedule. In performing this 7 day user-test certain specific objectives
(!	
shall be attained.
k	 SPECIFIC OBJECTIVES:
The specific objectives of the test shall be as follows: 	 -,
1. Effect of high frequency urine inputs on the bacterial contaminants 	 j
within the ABSS.	
7	 i
2. Effect of Betadine on
a) Typical urinary bacterial infection (E. coli)
• In vivo (within the ABSS)
e In Vitro (standard disinfectant titration)
b) Preliminary assessment of long term ei"fects of Betadine on	 7
the urine within the waste "holding tank".
h
3. Examination of the capability of the Microbial Sampler (MS) to 	 7
quantitatively sample the urine stream,
BASELINE CONDITIONS:
•	 y
The following conditions are considered as baseline for the 7-day trial with
the ABSS:
• Test days will be a total of 7 but not necessarily continuous, e.g.
no operation over weekend is planned.	 x
x,
Day	 12 hours.
"	 s Use of male and .female urine.
`	
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9 Minimum urine inputs/day = 10; up to 12-15.
e, Entire system will be sterilized before start of 7 day trial including
fluid pathways within ABSS and rinse water reservoir.
Assay of Betadine activity will be pe;°formed according to a reference
technique (separate protocol).
• Disinfect cycle will be operated once each operational day.
• "Loaded" (i.e., addition of bacteria) urine samples will be inserted
into the ABSS each day.
e Each urine input will be sampled for control on initial level of
bacterial organisms.
9 Selected urine effluents will be collected and sampled at the Sample.
Port only - approximately 4/day..
e All urine effluents to "Waste" will be collected in common holding
tank and the pool will be sampled once each operational day and
titrated for microbial activity.
• Microbial Sampler tests will be performed in duplicate (freezing
versus non-freezing as per protocol developed during earlier phase
of program).
MATERIALS NEEDED:
1. Sterile urine collection containers - approximately 120 required
(purchase from Fisher-Falcon Plastics).
i
2. Sample port collection containers - 250 ml flasks without stoppers
' and air vent - need approximately 25.
3. Betadine disinfectant - needed ti 420 ml undiluted as supplied by
:. manufacturer. a
' 4. Large glass carboy for effluent waste pool - sterile, with air vent,
etc.	 15	 liter 'size.
5. Culture media requirements
a.	 Trypticase Soy Agar
•	 Samples - 4/day x 3 dilns. x 2
-plates/diln. x 7 days
	
=	 168 plates
Microb. Samplers - 4 samples x 3
;= dilns. x 3 plates/diln. x 2 tests	 =	 72 r,
•	 Waste Pool = . 2 samples/day x 3 dilns.
^
x 2 plates/diln. x 7 days	 =	 42
-
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a.	 Trypticase Soy Agar (Continued)
e	 Urine Sterility Check	 10/day x 2
plates/sample x 7 _days	 140
--F27-p 1 a t e sSub Total
+ 10%	 42
Grand Total
	 64 plates
ml/Plate	 20
9no ml
Grand Total	 10 liters media	 20 flasks with
500 ml/flask
b.	 Dilution blanks - water
9 ml blanks = 80 tubes (2 racks)
99 ml blanks = 80 bottles
c.	 Trypticase Soy Broth - 250 ml screw-cap flasks with
50 ml/flask = 25 flasks, sterile.
6. Test Organism - Escherichia coli	 (ATCC #15144)
7. Pipettes - I ml	 (Sterile)	 As Required
5 ml	 (Sterile)	 As Required
10 ml	 (Sterile)	 As Required
8. Peracetic Acid - 2% Solution
Prepared as follows:
"Nacconol" - 0.5 ml
Perac-etic Acid -.50 ml
	 cf 40% solution.
QS with H2O - I	 liter
9. Cold Sterilized rinse water reservoir for ABSS
0	 150 mm filter holder
0	 0.22 filter
0	 Large Millipore SS pressure vessel filled with distilled H2O.
10. Large volume pipettes for sampling waste urine pool.	 25 ml, sterile
10 needed.
11. Sterile H2O, liter quantities, 1-liter flasks - need 5.
12. Sterilize Microbial Samplers 	 with gauze wi-, k at 1200C for 24 hours
6 needed.
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PROCEDURE/TIME-LINE
Pre-Test Activities - (3 to 5 Days Before Start Date)
1.' Connect filter system to ABSS, check for leaks and make
assay of effluent rinse water sterility with TSB - 3,
preliminary
10 ml	 samples.
W
2. Flush two 500 ml portions of 2% peracetic acid through ABSS,
•	 Allow 2 re-circulate cycles to operate, then turn off ABSS.
p' a	 Wait 15 minutes.
Turn	 on and allow complete cycle to operate•	 p	 Y	 p have sam 1e^	 P
s receptacle ready),
^ •	 Flush thoroughly with 4, 500 ml	 quantities of sterile H2O.	 -
•	 Check effluent water on both sample and dump ports for
sterility on last flush - 3 x 10 ml samplesin TSA.
Pre-Test
- (1 Day Before Start Date)
1.1 Install waste jug to system.
2. Fill disinfectant reservoir with Betadine to provide a final flush
concentration of 300 ppm.
3. Inoc.	 E.	 coli culture at 4 PM - in TSB at 37°C.
DAY 1 - WEDNESDAY SAMPLE NO.
0-1 Hour -Take pre-sample for Bacteria Check 1-1	 r
-Add E.
	
coli to urine sample to ti 10 6 org/ml,	 i.e.
approximately 1 ml	 undil. culture/140 ml	 urine.
-Add "Loaded" sample to ABSS and collect sample 1-2
-Pre-samp 1e,	for 2nd urine 1-3
-Process 2nd urine sample 1-4
1-10 Hours -Process each sample through ABSS and plate pre- 1-5
sample only (2 x 1 ml) 1-6
1-7
1-8
1-9
1-10
8 Hour -Inoc. E. coli flask
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SAMPLE NO.
10 Hour -Pre-sample	 Sterility	 Urine 9 1-11
Sample	 Urine 9 1-12
-Disinfect cycle
11 Hour -Pre-sample	 Sterility (Urine 10) 1-13
sample 1-14
DAY 2	 THURSDAY
0-1 Hour -Sample Waste Pool 2-15
-Pre-sample (Urine 11) 2-16
Sample	 (Urine 11) 2-17
-Pre-sample (Urine 12) 2-18
Add E. coli	 to Urine 12 as 'in Day 1
-Insert microbial sampler MS in urinal and pour
50 ml of loaded urine over MS, remove and label. 2-MS-1
0-1 Hour -Continue with-3 samplers more, using 2-MS-2
N : 50 ml portions each time. 2-MS-3
2-MS-4
-M-cap MS-3 and MS-4 and place in freezer
compartment at -180C.
-Allow all accumulated "loaded" urine to 2-19
process and collect sample.
I Hour -Pre-sample (Urine 13) 2-20
Sample	 (Urine 13) 2-21
1-10 Hour -Process additional urine with 	 (14) 2-21
Pre-samples only.	 15 2-22
16
117
2-23
2-24
(18 2-25
8 Hour -Inoc. E. coli flask.
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2-28
2-29
3-30
3-31
3-32
3-33
3-34
3-35
^ I
SAMPLE NO
10 Hour	 -Pre-sample (Urine 19)	 2-26
Sample	 (Urine 19)	 2-27,-
-Disinfect Cycle
-Pre-sample (Urine 20)
Sample
	
(Urine 20)
DAY 3 - FRIDAY
0-1 Hour
	
Sample Waste Pool
Pre-sample (Urine 21)
Sample
'-Pre-sample (Urine 22)
-Add E. coli and process through sample
tu
	
1 Hour	 -Pre-sample (Urine 23)
r-__.	 -_, 3	..-...	 -r-_.....,	 -_ ­_ 1 w ♦ c)	 V1GQI$P
and re-sterilize; then re-connect to system. I.
' -Re-fill Betadine reservoir with TBD concentration of
Betadine and re-insert into ABSS.
8 Hour -Inoc.	 E. coli flask.
DAY 4 - TUESDAY
-
5
-Follow Schedule for DAY 1, 4-47 c
thru
4-60
DAY 5 - WEDNESDAY
-Follow Schedule for DAY 2 including Microbial 5-61 r;=
thru
Sampler Expt.
	
5-MS-1 5-76
thru
5-MS-4
DAY 6 = THURSDAY
-Follow Schedule for DAY 3. 6-77 _.
thru
6-92
DAY
, 7,	 - FRIDAY
-Follow Schedule for DAY 3 - take last Waste Pool 7-93
sample immediately after last urine sample
	 not thru ,>
Saturday morning. 7-108
:fit -88-. a.Y ..
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4.1.9 Quantitative Recovery Of Bacteria From Microbial Samplers
Purpose
To study the quantitative recovery of urinary bacterial contaminants captured
by the wick in the Microbial Samplers (MS) during operational use.
Objectives
Determine within the limits of the techni ques, the capability of the MS to
provide quantitative bacterial recoveries from urine streams containing
representative bacterial contaminants.
Materials Required
1. Microbial Samplers containing standard amounts of gauze wicking and
sterilized at 120°C for 20-24 hours - 5 needed.
2. Bacterial recovery flasks - 500 ml screw-cap flasks containing
47 ml of `Y`rypticase Soy Broth (TSB) - 10 needed.
3. Dilution Blanks - water
3 ml blanks - 10 needed
9 ml blanks - 25 needed
4. Agar Trypticase Soy Agar (TSA)
8 Samples x 3 Dilutions/Sample x 3 Plates/Dilution 	 72 Plates''
Agar/Plate
	 20
1 0 ml
1.5 liters of TSA required
5. Pipettes
1 ml - sterile as required
5 ml - sterile as required
6. Urine sample containing typical urine contaminant - at least 250 ml^,	 a
=Y	 urine containing approximately 106 organisms/ml of E. coli.
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7. Urinary test organism - E. coli (ATCC #15144).
Timel i ne/Precedures
Test No. 1
Thursday - Capture of Bacteria
Add fresh 18 hour E. coli culture to urine sample to provide w 106
organism/ml as per directions in Main Protocol under Day 1.
• Insert first MS sampler into urinal.
e Pour 50 ml (+ 2-3 ml) portions of the 11 Loaded” urine over MS and
into phase separator of ABSS.
e Remove MS, replace with fresh, sterile MS andrepeat with another
50 ml portion.
• When all 4 MS have been employed as described above titrate immedi-
ately as per following instructions.
• Place wire mesh and gauze wick into 50 ml TSB, place flask on 	 1
Eberback shaker and secure firmly on tray. Operate shaker at ti
40-50 excursion/minute for 15 minutes.
e Remove l-ml of resulting suspension and place in 3 ml blank - this
will provide a dilution of approximately 10-2.
• With this dilution, place 3,0.1 ml portions into 3 petri dishes and 	 '
E
I
Monday.
d' Test No. z
Wednesday
Y
p •	 Repeat as in Test No. 1.
9
1
I
I
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4.1.10	 Protocol For Determining Efficacy Of Betadine For Use In ABSS Urine System
t
1.0	 INTRODUCTION
Betadine, the Purdue Frederick Company's' water-soluble complex of iodine
and polyvinylpyrrodidone (Povidone) which when mixed with water possesses
the well-known.antiseptic properties of iodine, has been considered for use
as a disinfect for the ABSS Urine Sampling Subsystem.
I ;	 2.0	 OBJECTIVES
The following objectives have been established to determine the capability
of Betadine as the ABSS disinfection agent:
f
1)	 To disinfect the ABSS hardware, under typical or normal use
'	 conditions.
2)	 To "hold in check", the microbial population, in the collected
n
.
pooled waste urine.
3.0	 DISCUSSION
`	 The overall objectives are to determine, by test, if tfie ABSS Urine Sampling
Subsystem hardware (hard, non-porous surfaces) can be disinfected and that
concentration of Betadine germicide which can be used to reliably disinfect them.
Since the 7-Day usage test will employ daily additions of typical urinary
bacteria, this protocol 	 is designed to provide basic data on the efficacy
of Betadine, both diluted in water and Betadine diluted in freshly collected
urine,	 to inactivate a viable test culture of E. col i . i
The protocol also designates a method for chemically assessing the level of
freely available iodine in the test solutions of Betadine and the residual
Betadine in the pooled waste urine..
E: ^^ 371
Purdue Frederick Company and Affiliates. 99 Saw Will River Road. Yonkers.
N. Y. 10701; Executive Offices 15 East 62nd Street, N. Y., N. Y. 10021
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11, 4.1.1 Prepare in duplicate the following dilutions of Betadine, in both
water and urine, using 250 ml wide-mouth Erlenmeyer flasks, so that each
flask contains . 100 ml:
Concentration Of Betadine Available Iodine (ppm)
1	 Undiluted (10% as supplied by manufacturer) 1% or 10,000 ppm
2)	 1:1	 (5% Betadine) 0.5% or 5,000 ppm
3)	 1:10 (1% Betadine) 0.1% or 1,000 ppm
4)	 1:30 (0.30%.Betadine) 0.30% or 300 ppm
5)	 1:100 (0.1% Betadine) 0.010% or 100 ppm
6)	 1:7000 (0.01% Betadine) 0.001% or 10 ppm
4.1.2	 Place . each set of flasks in constant temperature both at 25°C and
hold until stable temperature is obtained (minimum of 20 minutes hold time).
4.1.3	 Prepare similar flasks containing:
4.0 PROCEDURE
4.1 Efficacy of Betadine in water and urine.
a) 99 ml of sterile phosphate buffer dilution water. (See Section 5.5 & 5.6)
b) 99 ml sterile neutralizer solution. (See Section 5.3 & 5.4)
a
0.4 Add l ml of culture suspension (ti 108 organisms per ml) to each test
flask as follows: Swirl flask, (avoid foaming) stopping just before suspension
is; added, creating enough residual motion of liquid to prevent pooling of
suspension at point of contact with test germicide. Add suspension midway'
jL «
between center and edge of surface with tip 0 pipet slightly immersed in
test solution. Avoid touching pipet to neck or side of flask during
addition.
4.;1.5 Transfer 1 ml portions of the exposed culture to neutralizer blanks
exactly 1 and 30 minutes after addition of suspension. Mix immediately
after transfer.'
r
t	
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i4.1.6 For "numbers control" (assay of suspension of test organism), add
1 ml of culture suspension to 99 ml sterile phosphate dilution water.
4.1.7 For "toxicity check" on neutralizer solution, add l ml of culture
suspension to 99 ml sterile neutralizer solution.
4.1.8 Plate from neutralizer tube to agar, using subculture medium (Trypticase
Soy Agar) for germicide test dilutions and Trypticase Soy Agar and/or Eosin
Methylene Blue Agar for numbers control. For dilutions to give countable.
plates, use 99 ml sterile phosphate buffer dilution water as follows:
4.1.9 Transfer 1 ml exposed culture (1 ml culture suspension transferred
to 99 ml phosphate buffer dilution water in H2O bath) to 99 ml phosphate
buffer dilution water (dilution A). Shake thoroughly and transfer 1 ml
dilution A to 99 ml phosphate buffer dilution water (dilution B).
4.1.10
	 Shake thoroughly and plate three 1.0 ml and three 0.1 ml aliquots
from dilutions A and 6 to individual sterile petri dishes. 	 Add approximately
1'0-15 ml of the molten sterile culture medium to each plate, swirl and allow
agar to harden.	 Incubate plates at 35 0C in inverted position. 	 Record the
3
:x
number of colony-forming units at 24 and 48 hours.
x
4.2	 Efficacy Of Betadine In Pooled Waste Urine
Sample of urine collected in the sterilized waste receptacle will be removed
at appropriate intervals and aliquots added to dilution solution containing
the antimicrobial ;neutralizer.	 These dilutions will be assayed for viable
r
organisms (according to Section 4.1-.2 through 4.1.10). K
T
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4.3	 Determination Of Available Iodine In Betadine Solutions
Schmidt andWinicov (1967) have summarized the res , ilts of assessing various
1
detergent/iodine systems for the iodine present and clarify the various terms
K
as follows:
Total	 Iodine
Volhard Iodine
Available Iodine
Complexed Iodine
Free Iodine (I2)	 Uncomplexed Iodine.or
The technique for best determining that portion of the available iodine which
is not complexed is by determining the distribution of iodine between the
aqueous (product) phase and an organic solvent such as heptane. 	 The fol-
lowing Distribution Coefficient (D.C.) procedure can be used to determine
the free iodine.
The D.C.'Method
The Distribution Coefficient (D.C.) is determined by adding 1.00 ml of
{[ standardized test solution containing between 0.05 and 5.0% iodine to a 50 ml
graduated cylinder containing 25 mis purified n-heptane. 	 The temperature
of the heptane is brought to 25 0 + 1°C.	 The cylinder is stoppered and shaken
vigorously by hand for one minute during which time the aqueous solution
suspends in the heptane as a- uniform haze.	 The solution is the y allowed to
stand a minute or two, and the temperature adjustment and shaking aref
repeated.	 For best results the solution should settle for an hour before a
the iodine determination.
1
t
..
F
t
V*t
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The amount of iodine in the heptane layer is determined colorimetrically at
520 m;l, the absorption peak; the relationship between light absorption and
iodine concentration in this solvent is linear throughout the range of one
to 25 mg per 100 mis. The distribution coefficient is calculated by the
following formula:
D.C.	
m I remaining in
	 X mis heptane
	mg I in heptane
	
mis aqueous phase
Using the Beckman DU spectrophotometer with 1.00 cm cells, an absorption of
a
0.142 corresponds to 1.00 mg iodine extracted by 25 mis heptane. Values so
obtained are readily reproducible to within 10% and frequently to within 1%.
The D . C.  as defined here parallels iodine complexing in that the greater
the complexing, the higher the D.C. number. For a given available iodine
concentration the D.C. values are dependent upon the iodine and detergent
levels.
A satisfactorily complexed iodine product is one which is characterized by
.^x
a D.C. number in the range of about 150 to 300 for 1.75% available iodine; .LL
content.
5.0 Materials And Reagents
5.1 Culture. Medium
-a) Trypticase Soy Broth - Prepare as indicated by manufacturer on
bottle. Place 50 ml in 250 ml cotton Stoppered Erlenmeyer flasks
and autoclave 20 minutes at 121°C. Use for daily transfer of test
culture.
96-
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4 5.2	 Subculture Media
y
a)	 Trypticase Soy Agar - Prepare as indicated by manufacturer on bottle.
Place 250-300 ml in 500 ml screw-capped Erlenmeyer flasks and
EL' operations.
autoclave 20 minutes at 121°C.	 Use for all subculture and plating
b)	 EMB (Eosin Methylene Blue) Agar, - Prepare as indicated by manu-
facturer.	 Place 250-300 ml in 500 ml screw-capped Erlenmeyer flasks
and autoclave 20 minutes at 121°C.	 Use as subculture plating medium
-+ to identify E.	 coli.
5.3	 Neutralizer Stock Solution
A
k. Sodium Thiosulfate Solution - Dissolve 40 grams of Na2S203 in screw-capped x
water blank bottles and autoclave 20 minutes at 121°C. 	 Use concentration is
1 ml of this stock solution to 99 ml phosphate buffer blanks.
•	
N
5.4	 Neutralizer Blanks
Add 1 ml of Sodium Thiosulfate neutralizer stock solution to each 99 ml
phosphate buffer dilution water.
u
_1
5.5	 Phosphate Buffer Stock Solution
y.
0.25 M - Dissolve 34.0 gram KH2PO4 in 500 ml H2O, adjust to pH 7.2 with
1 N NaOH and dilute to 1	 liter. l
;
5.6	 Phosphate Buffer Dilution Water
Add 1.25 ml of 0.25 M phosphate buffer stock solution to 1 	 liter of water
and dispense in 104 ml amounts in 99 ml scree-capped water blank bottles.
a
Autoclave 20 minutes at 121°C.
1
r
5.7	 Test Organism
Use Escherichia-coli AtCC No. 15144.	 Maintain stock cultures on nutrient
agar at refrigerator temperature.
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5.8	 Apparatus
a )	 Glassware
TBD
i
b)	 Petri Dishes
TBD
r
c)	 Water Bath
TBD
6.0	 REFERENCES
Horwitz, W.	 (ed)., 1970,	 Germicidal and Detergent Sanitizers pp E6-68:
Disinfectant,s.:	 Chapter 4 in Official Methods of Analysis of the Association -
of Official Analytical Chemists.	 Eleventh Edition, Association of Official 
Analytical Chemists, P. O. Box 540, Benjamin Franklin Station, Washington,
D.	 C. 20044.
R
..
Schmidt, A. M., 1974.	 Guidelines for Safety and Efficacy Testing of OTC Topical
Antimicrobials Federal Register; Part II, Volume 39, Number 179, Friday,
September 12, 1974, Washington, D. C.
Bruch, M.	 K.	 1975	 Personal Communication,.
Uetergent/Iodine Systems.
	 SoapSchmidt, W., and Winicov, M.,	 1967.	 and
Chemical Specialties 43, 61-64..
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Phosphorus (Inorganic) in Serum or Urine
PRINCIPLE
A trichloracetic acid filtrate is treated with ammonium
taolyhdate solution (molybdic acid), which combines with
phosphate to form phosphomolybdate. The molybdate thus
formed is reduced with ferrous sulfate and the blue color
produced is measured photometrically and is proportional
to the amount of phosphorus originally present.
REAGENTS
1. 7:richloracetic acid, 12.0% (iv/ v).-Dissolve 120.0 gm.
of trichloracetic acid in water and dilute to exactly
I liter.
2. Trichloracetic acid, 34.0% (w/v).-Dissolve 340.0 gm,
of trichloracetic acid in water and dilute to exactly
1 liter.
3. Sulfuric acid, 10 N.-Add slowly to about 700 mi. of
distilled water 278 ml. of concentrated sulfuric acid.
Cool, and, dilute to 1 liter with distilled water.
4, rtmmonium itiolybdate, stock solution, 10 17o.-Add 50
gm. of (NH,),,Nfo;0.,, • 4H,0 into a liter beaker and
add 400 nil. of 10 N sulfuric acid with constant virring
to prevent caking. When completely dissolved, transfer
the solution to a 500 ml, volumetric flask and wash in
quantitatively with 10 N sulfuric acid to the mark.
5. Ferrous sitl/ate-aininoniuvt n ►olyhdaie reagent.-Prepare
just prior to using, Transfer 10.0 ml of ammonium
molybdate stock solution to a 100 ml volumetric flask
and dilute to about 70 nil. Add 5,0 gm. of FeSO, • 71 ­11_O,
make up to volume with water and shake until the
crystals are dissolved. Transfer to a brown glass bottle.
PROCEDURE, (Serum)
tt 	 1. To a test tube containing 3.5 ml. of 12% trichloroacetic
.6 acid acid 0.20 nil. of serum, mix, allow to stand for 10
minutes and then centrifuge rapidly for 10 minutes. In-
elude a bank containing 0.20 ml. water and 3.0 ml. of
12% trichloracetic acid.
2. Transfer 3.0 nil. of the clear supernatant filtrate to a
cuvettc and add 2.0 nil. of ferrous sulfate-molybdate
;. a	 reagent.
3. After 1 minute (or within 2 hours) read the unknown
against the blank at a wavelength of 640 mp using the
red filter (33-29-18). it is recommended that the red
sensitive phototube (33-29-72) be installed for these
measurements.
4. Refer. to the table below to determine the concentration
of phosphorus as mg. P; 100 ml. serum. STANDARDIZATION
PROCEDURE, (Urine) Prepare a stock standard solution by dissolving 0.1196 gm.
1. Dilute 4.0 nil. of the urine specimen to 100 nil This of anhydrous potassium dihydro^,,en phosphate in water and
n	
' dilution will suffice with most urines. If, 6o+wever, this diluting to exactly' 	 100 ml. This solution is stored' in the
dilution factor yields a final color too light or too dark, refrigerator, Two working standard solutions containing re-
another appropriate dilution is selected. spectively, the equivalent of 5.0 and 10.0 mg. P per 100 nil,
of serum are prepared by appropriate dilution and acidifi-
,. 3. Transfer 2.0 nil. of the diluted urine to a cuvette and add cation of the aqueous stock standard solution in the follow-
1.0 nil. of 34%	 trichloracetic acid. 	 (if the urine con- ing +vay: Dilute 1,0 and 2.0 nil. of the stock standard solu-
twins proteins a turbidity will he 'produced after the ad- lion to exactly
	 100 ml. with
	
I l.5 ric	 (+w v)	 trichloracetic
dition of the trichloracetic acid. In this case. proceed as acid. These solutions are stable for about 3 weeks when
follows:	 Pipette 4.0 nil. of diluted urine from step 1 kept in a refrigerator.	 Exactly 	3.0 nil.aliquots of these
into a test tube, add 3.0 nil of 34 ri trichloroacetic acid, working standard solutions are analyzed by the same pro-
mix and allow the mixture to stand at room teen crature)' cedure that is used for serum filtrates (steps 2 and 3). Re-
for about 10 minutes. After centrifuging. pipette 3.0 ml. cord the A or rc T and prepare a calibration table or curve
of the supernatant fluid into a cuwcttc and proceed with as desired. A typical calibration table is given below,
the following.)
a• 3. ;add 10 nil. of the ferrtxn sulfMC-11i010date ►•c.: ent and
41 read as with scrum (step 3 above). REFERENCE
4. Refer to the table below to determine the concentration 1. 1'axtssky,	 H. H., and Shorr,
	 E,, J.	 Biol.
	
Cheim, 202, .
of phosphorus as m g. P
	
I nil. urine. 675.655 ( 1953).
^	 at
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